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Abstract
In 2018, Medicare spending in the United States accounted for 15% of the comprehensive
federal budget forecasted to exceed $1.5 trillion by the year 2028. To help manage the
spending in this sector, the Centers for Medicare and Medicaid Services implemented
Medicare Shared Savings Program (MSSP) Accountable Care Organizations (ACOs).
There is a need to understand current data as it relates to the correlation between MSSP
ACO participants’ costs, quality, and assigned beneficiaries. The purpose of this
quantitative study was to examine the relationship between Quality Score, Generated
Total Savings/Losses and Total Assigned Beneficiaries for 2018 MSSP ACO
participants. General systems theory was the theoretical base that grounded and
conceptualized this study. The key research questions examined the relationship between
the Quality Score and Generated Total Savings/Losses for 2018 MSSP ACO participants
and the relationship between the Quality Score and Total Assigned Beneficiaries for 2018
MSSP ACO participants. The research design was that of secondary data quantitative
analysis. The analytics stem from public CMS data. Even though the data analysis results
showed no statistically significant relationship between Quality Score and Generated
Total Savings/Losses nor between Quality Score and Total Assigned Beneficiaries for
2018 MSSP ACO provider participants, this study contributed to positive social change
by creating a new vantage point for review of their quality, costs, and assigned
beneficiaries. The development and understanding of ACO initiatives are essential pieces
required for meeting federal value-based care and alternative payment model U.S. health
care goals.
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Section 1: Foundation of the Study and Literature Review
Fragmentation and misalignment in the U.S. health care system created an
opportunity for reforms of its payment and delivery methods. Traditionally, U.S. health
care has reimbursed providers via fee-for-service (FFS) payment structures. FFS has had
an unintended consequence of incentivizing volume (or increasing number) of services
over quality, outcomes-based, or higher value services. There have been various
historical attempts to rein in health care costs while concurrently increasing quality; with
a goal of improving overall delivery. As an example, the overarching Accountable Care
Organization (ACO) model has a modern goal of improving population health and
reducing per capita costs (Tu et al., 2015). The Centers for Medicare and Medicaid
Services (CMS) created ACOs in Section 3022 of the Patient Protection and Affordable
Care Act (ACA) of 2010 as an Alternative Payment Model (APM) to begin the shift of
the U.S. health care environment from volume to value. Title 42 CFR Part 425 (2018)
outlined the requirements for participation in the Medicare Shared Savings Program
(MSSP).
As detailed in the literature review, Medicare ACOs have various strategies in
terms of the different offerings and participation numbers in each performance year. The
MSSP is the largest ACO developed to date. No termination currently exists for MSSPs.
On the contrary, MSSPs have been further recognized and empowered via the passing of
the Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization
Act (MACRA) of 2015. The MACRA’s Quality Payment Program (QPP) includes a
component of achievement that relies on MSSPs being successful (TXCIN, 2018).
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In 2013, the CMS implemented the MSSP, a years-long strategy and
multipronged approach to help reform Medicare and ensure the sustainability of the
sector. In essence, MSSP ACOs agree to be accountable for the patient experience, cost,
and quality of their assigned Medicare FFS beneficiary population. (TXCIN, 2018).
Spending on Medicare is nearly one fifth of total U.S. health care costs (Cubanski
et al., 2019). To help better manage the spending of the Medicare sector of the U.S.
health care industry for taxpayers and concurrently promote high-quality care for
beneficiaries, the CMS has implemented MSSP ACOs (CMS, 2019). This study reviewed
the Total Assigned Beneficiaries, Generated Total Savings/Losses and Quality Score of
2018 MSSP ACOs. This study needed to be conducted on a micro level to note the 2018
performance year relationship of quality and cost indicators for the managed population
of the MSSP. On a macro level, this study needed to be conducted to understand the
impact MSSPs are having on the overarching U.S. health care goals to increase quality
and decrease costs for managed populations in the Medicare space, moving more towards
value-based care. The positive social changes of this study include understanding the
relationship between quality, cost, and total assigned beneficiaries and related movement
toward value-based care in terms of lowered costs and increased quality for the U.S.
health care system, specifically stemming from 2018 MSSP ACOs. From a quality
perspective, this is critical for Medicare beneficiaries, and from a cost perspective, this is
important for U.S. taxpayers.
The major sections of this chapter include (a) Problem Statement; (b) Purpose of
the Study; (c) Research Questions and Hypotheses; (d) Theoretical Foundation of the
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Study; (e) Nature of the Study; (f) Literature Search Strategy; (g) Literature Review
Related to Key Variables and Concepts; (h) Definitions; (i) Assumptions; (j) Scope and
Delimitations; and (k) Significance, Summary, and Conclusions.
Problem Statement
Per the U.S. Department of Health and Human Services (DHHS, 2019), Medicare
spending is forecasted to exceed $1.5 trillion by 2028. Medicare-specific costs account
for about 20% of the total health spending nationwide. In 2018, Medicare took up an
estimated 15% of the comprehensive federal budget (Cubanski et al., 2019). To manage
the spending of this sector of the U.S. health care industry for taxpayers and concurrently
promote high-quality care for Medicare beneficiaries, the CMS has reviewed new and
innovative ways to move away from FFS with a focus toward value-based care payment
models. The payment models seek to reward providers for the overall value (measured by
decreased cost and improved quality) of health care services. To date, although the CMS
has implemented an array of APMs to achieve its goals, the MSSP, founded in 2010, is
one of the center’s largest APMs to encourage cost efficient and quality care services
(CMS, 2019). Mostashari and Broome (2016) reported that there is still much debate over
whether ACOs have been successful in delivering value. Wegner (2016) defined health
care value as a measurement of the quality of care and cost of care. Falk (2016) noted that
if the CMS is sincerely interested in seeing Medicare reimbursements tied to value,
confidence in the future of MSSPs must be instilled; additional research can work to
reveal whether it takes further participation in accountable care to realize the full effects
that coordination efforts can have on the cost and quality of U.S. health care.
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Previous research has shown that there is a need to understand future years’ data
(Falk, 2016) as it relates to whether MSSP ACO participants render health care services
to their total assigned beneficiaries that are of lower cost (i.e., by means of generated
CMS cost savings) and higher quality (i.e., determined via established benchmarks and
quality improvement efforts), thereby demonstrating a gap in research. Falvey (2017)
mentioned that health care leaders who have launched ACOs, or debate the future of
population health, need results generated from studies such as this to maintain current
ACOs and their strategic approach while also potentially demonstrating the need to
establish additional ACO-like initiatives. The development of ACOs is the essential piece
required for managing an assigned beneficiary pool via population health management.
MSSP ACOs were established by the ACA to implement initiatives aimed at reducing
costs and improving care for an assigned beneficiary pool (Corder, 2018). Perez (2015)
posited that ACOs have the most significant potential to concurrently lower costs and
improve quality. This research is important to the health care administration discipline for
many reasons, but most importantly, to understand the relationship between costs,
quality, and assigned beneficiaries within MSSP ACOs, specifically in the 2018
performance year.
Purpose of the Study
This study utilized a secondary data quantitative approach to address the research
questions. The statistics consisted of public data from CMS, a federal resource, for the
MSSP ACO 2018 performance year. This allowed me, as the scholar-practitioner, to
employ recent data via a standard analytical file that was used to efficiently summarize
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information for beneficiaries and providers for the specific ACO 2018 performance year
of the MSSP. The research demonstrated that MSSP ACOs are an avenue that can be
utilized to ensure lower costs and increased quality as it relates to serving the Medicare
FFS population. With a national gross domestic product (GDP) of nearly 20% (Cubanski
et al., 2019), the United States must roll back the unconscionable costs and crouched
quality that resides in its health care renderings to ensure sustainability and affordability
for the entire system; innovation in the Medicare space is critical to the larger goal.
The purpose of this quantitative study, which differentiates it from others
published, was to understand the relationship between Quality Score and Generated Total
Savings/Losses within MSSP ACO participants in the 2018 performance year and to
understand the relationship between Quality Score and total assigned beneficiaries within
MSSP ACO participants in the 2018 performance year. The literature notes that MSSP
ACOs are a viable option for U.S. health administrators to reach systemic goals due to
their effect on cost and quality; they can not only save the federal government, revenue
via taxpayers, billions of dollars as years progress and initiatives become more innovative
and collaborative, but also ensure care quality is enhanced (National Association of
ACOs, 2018). The need for this study lay in noting the relationship between certain
variables to review and understand how MSSP ACOs can improve quality and costs
savings, allowing for further expansion of accountable, value-based care.
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Table 1
CMS Variables with Short and Long Descriptions
CMS
variable
N_AB

CMS short
description
Total assigned
beneficiaries

CMS long description
Number of assigned beneficiaries, performance year

GenSaveLoss Generated total (Gross) Generated savings: Total savings (measured
savings/losses as Benchmark Minus Expenditures, from first to last
dollar) for ACOs whose savings rate equaled or
exceeded their Minimum Savings Rate (MSR). This
amount does not account for the application of the
ACO’s final sharing rate based on quality
performance, reduction due to sequestration,
application of performance payment limit or
repayment of advance payments. (Gross) Generated
losses: Total losses (measured as Benchmark Minus
Assigned Expenditures, from first to last dollar)
ACOs in Track 2, Track 3, or the Track 1+ Model
whose losses rate equaled or exceeded their Medical
Loss Ratio (MLR). This amount does not account for
the application of the ACO’s final sharing rate based
on quality performance (for Track 2 or 3 ACOs) or
the loss sharing limit.
QualScore
Quality score
Quality score: In Performance Year 1 of an ACO’s
first agreement period, the quality score is 100% if all
measures were completely reported and less than
100% if one or more measures were not completely
reported. Beyond Performance Year 1 of an ACO’s
first agreement period, the quality score will be
determined not only by whether all measures were
completely reported but also on their performance
against established benchmarks and on quality
improvement. For ACOs determined to have been
affected by a natural disaster, the quality score is the
higher of the ACO's calculated initial quality score or
the national mean quality score across all Shared
Savings Program ACOs who met the quality
performance standard.
Note. (Centers for Medicare & Medicare Services, 2020)
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The study’s variables were Generated Total Savings/Losses, Quality Score, and
Total Assigned Beneficiaries. For Research Question 1 (RQ1), the study’s independent
variable (IV) was Quality Score and the dependent variable (DV) was Generated Total
Savings/Losses in the 2018 MSSP ACO performance year. For Research Question 2
(RQ2), the study’s independent variable was Total Assigned Beneficiaries and the
dependent variable was Quality Score in the 2018 MSSP ACO performance year. The
definitions of variables are presented in Table 1 and in the Definitions section of this
study.
ACO Tracks (inclusive of Track 2, starting in 2012, and Track 3, starting in 2016)
vary in terms of their financial structures, beneficiaries, data and quality reporting
requirements, compliance, and waivers. Medicare requires ACOs to report the quality
measures which are composed of 33 nationally recognized measurements in four
categories: patient experience, care coordination/patient safety, preventative health, and
five different at-risk populations. Afterward, the Quality Score is determined not only by
whether measures were completed reported or not, but also on the ACO’s performance
against certain quality improvement initiatives and established benchmarks (CMS, 2020).
Research Questions and Hypotheses
RQ1: Is there a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants?
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H01: There is no statistically significant relationship between the Quality Score
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
H11: There is a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
RQ2: Is there a statistically significant relationship between the Quality Score and
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable
Care Organization participants?
H02: There is no statistically significant relationship between the Quality Score
and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
H12: There is a statistically significant relationship between the Quality Score and
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable
Care Organization participants.
Theoretical Foundation for the Study
General systems theory (GST) is the theoretical base that grounded and
conceptualized this study. Von Bertalanffy (1968) wrote that a system is complex with
interacting elements, continually evolving parts, and emerging properties. GST covers
broadly applicable concepts and principles in dynamic and active systems with
behavioral and process-based interactions. The theory allows the researcher to review the
various layers that exist in the system to relate them and study their intersecting trends
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and patterns. GST is a framework that can be used to help understand, design, and
analyze ways to investigate how value-based care may help improve the U.S. health care
system and understand the relationship among the related variables such as quality, cost,
and beneficiaries. The theory can help examine specific MSSP ACO performance years
and note how those ACOs behave in the ever-changing health care environment, specific
to quality, costs, and beneficiaries.
In this particular study, the way quality, cost of care and assigned population push
and pull on each other in the overall system were studied in terms of their interrelatedness
and their interdependence in health care to better understand effects on affordability and
sustainability. The advent of MSSP ACOs has created an avenue of accountability
whereby Medicare costs can arguably be contained and measured, and actionable insight
can be offered via coordination and the encouragement of investing in efficient services
(CMS, 2019). This layer of an already complex overarching system will give rise to
picking apart specific quality, cost and beneficiary data that can be extracted to
understand the relationship and positively impact the whole. The variables of this study
were related to GST in part because although there are multiple outcomes that MSSP
ACOs measure to ensure efficient, coordinated care, quality scores are key clinical
metrics with various elements that have a relationship with costs and assigned
beneficiaries and an effect on the overall system. A competitive strategic approach for
health care administrators leading various health care organizations is in many ways
dependent on properly understanding the relationship of quality and cost measures to the
population under organizational management (Arsita & Idris, 2019).
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Nature of the Study
For this study, I used a secondary data quantitative approach to address the two
research questions. The data statistics consisted of public data from CMS, a federal
resource, for the MSSP ACO 2018 performance year. This allowed me to employ recent
data via a standard analytical file that I used to efficiently summarize information for
beneficiaries and providers for the specific performance year of the MSSP. This research
study noted the relationship amongst cost, quality and beneficiaries and yielded thoughts
and potential further research on the notion that MSSP ACOs can help lower costs and
increase quality as it relates to serving the U.S. Medicare population. Since nearly one
fifth of the U.S. GDP is spent on healthcare (Cubanski et al., 2019), the nation must find
more innovative, sustainable, and affordable ways to render health care services.
Understanding the relationship between Quality Score, Generated Total Savings/Losses
and Total Assigned Beneficiaries can serve as a tool in the overarching review of MSSP
ACOs as an innovative opportunity to ensure sustainability and affordability of the U.S.
health care system.
Literature Search Strategy
Selected articles related to the study were found by searching keywords and/or
phrases such as CMS MSSP ACOs, Medicare Shared Savings Program, accountable
care, Accountable Care Organizations, value-based care in U.S., Medicare payment
innovation, alternative payment models, quality, cost, attributed beneficiaries, Total
Assigned Beneficiaries, Generated Total Savings/Losses, and Quality Score. Databases
used included, but were not limited to, EBSCOhost, CINAHL Plus with Full Text,
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MEDLINE with Full Text, ProQuest, and Science Direct. The scope of the literature
review spanned the years from 2015 to 2020. The types of literature used for this study
were peer-reviewed journal articles, reputable online and textbook works, as well as
esteemed commissions by distinguished, prominent, and renowned authors.
Literature Review Related to Key Variables and Concepts
In reviewing the literature as it relates to accountable health care in the U.S., I
analyzed peer-reviewed journal articles, dissertations, doctoral and master-level studies,
and other scholarly resources on the topic of accountable and value-based care;
specifically, transformation, initiatives, realizations, evolution and MSSP ACO
relationships.
Accountable Care Transformation
Fundamentally, the U.S. health care system has, for years, had perverse
incentives. Providers have been paid based mostly on the volume of services rendered
and when patients become/are sick. As a result of this historical volume-driven utilization
model, a new wave of outcome (or value)-based agreements is emerging from not only
Medicare payment methods, but also various commercial, Medicaid, as well as other
health plans and managed care organizations. These advents include quality measurement
and shared financial savings/losses with providers. When providers participate in valuebased health care models, there is an innate risk, sometimes inclusive of upside and/or
downside financial agreements. However, if and/or when providers accept the risk, they
will recognize that there is a correlated opportunity for greater incentives (Mostashari,
2018).
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Secretary of DHHS, Alex Azar, has declared that rendering value-based health
care in the United States must dramatically accelerate to deliver health care outcomes
commensurate with current and future health care costs (Leonard, 2018). Azar has made
it clear that the current, aforementioned volume-based, system is not working well
enough for Medicare beneficiaries nor taxpayers, and the U.S. health care system must
make more than just incremental steps in disrupting arrangements that currently exist
(Leonard, 2018). Failure to successfully incorporate accountable care into the
overarching system will likely result in monetary losses, less access to care for patients as
well as reduced quality of care (Pierce, 2018).
Historically, there have been mixed results in the research regarding population
health and its related impact and sustainability in terms of meeting cost and quality goals,
as noted in Leighton’s (2019) research on the provider and organizational response to
population health management initiatives. In the qualitative study, Leighton used
Medicare administrative claims data, observations, interviews, and document reviews to
understand better processes, structures, and performance between MSSP ACO provider
networks and maintenance of attributed beneficiaries. There have been organizations that
improved care processes and positively modified health care provider behavior, but
context matters when noting driving change factors and overall performance. The
adjusted logistic regression results indicated highly comprehensive ACO provider
networks having a positive impact on the retention of attributed beneficiaries.
Generalized linear models were used to test the hypotheses related to changes in provider
operations (Leighton, 2019).
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Transformation achievement in the U.S. health care system is extensive, timeconsuming, daunting, and undoubtedly feels foreign to some stakeholders. However, as
Medicare is currently the nation’s largest purchaser of health care in the United States,
and the MSSP is one of the broadest APMs, the federal payer, CMS, and related Center
for Medicare and Medicaid Innovation, has been the impetus for driving change.
Systemic, yet flexible; complex, yet straightforward – CMS has continued to forge ahead
with implementing various types of MSSP ACOs to ensure effective, coordinated,
fiscally responsible health care of sound quality for beneficiaries. ACOs are a vital
component of the overall U.S. health care long-term strategy in moving toward valuebased care. Medicare ACO design includes the provision of financial incentives to reduce
health care delivery inefficiencies for a specific population (TXCIN, 2018). Success of
value-based care and its ability to move the U.S. health care system toward higher quality
and lower costs will depend on understanding the markers of ACO success thus far, a
continuation of initiatives that have worked well, and a development of increased
innovation geared towards improved quality and reduced costs (Moloney, 2015).
In ACOs, alignment between hospitals and physicians on patient care is driven by
cost control and quality improvement endeavors. Clinical integration and
interorganizational relationships are aimed at minimizing constraints, improving
efficiencies, implementing strategies to address challenges related to limited resources,
and coordinating patient care between inpatient, outpatient, and physician office services
for appropriate care management as well as share centralized administrative services.

14
ACOs require meaningful collaboration as well as data sharing and integration (Harrison
et al., 2018).
Under FFS models, providers can receive reimbursement for tests and procedures
rendered with no reward nor penalty related to whether those services impacted patient
quality of care outcomes or costs (LaPointe, 2017). Accountable, value-based care via
APMs, however, creates a financial responsibility, or risk-based approach, for providers
as it pertains to the health care services provided. Upside risk, or one-sided financial risk,
allows provider participants to share in specific cost savings initiatives alongside the
payer if the providers’ rendered services make care delivery more efficient in higher
quality and lowered costs (LaPointe, 2017). If costs exceed the agreed-upon benchmark,
upside-only, or one-sided risk, provider participants do not qualify for any shared savings
payments or financial incentives, but those providers are not penalized; they are held
harmless from a cost perspective. Meaning, the upside-only, or one-sided risk provider
can earn a financial reward if they meet the benchmark, but, good for the provider, have
no chance of penalty if they do not meet the criterion. Upside-only, one-sided (payer) risk
arrangements are typically preferred by providers as the providers have no risk of losing
or paying back money to the payer; only an opportunity to be rewarded financially
(LaPointe, 2017). Downside risk, or two-sided risk, promotes accountability on behalf of
the provider in partnership with the payer. In this model, provider participants share in
financial savings and losses. The provider is at shared, two-sided, inclusive of downside,
the risk for saving and losing money in the shared-risk arrangement with the payer.
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Shared risk models do not always equate to fifty percent division; sometimes payers take
on more of the risk than the providers, for example. (LaPointe, 2017).
Kruthoff (2017) noted that the existence of downside risk, while currently still
voluntary, is an indication that the U.S. federal government looks to shift further and
scale more broadly to this kind of arrangement to transform the health care delivery
system to become more aligned with health and wellbeing goals. Advocates of population
health management may consider demonstrating the positive impact these changes can
have on more robust and greater structures.
Integrated health care delivery networks have an opportunity under ACO program
rules to function as population health networks (Falvey, 2017). These networks integrate
clinical processes to improve outcomes for certain populations while reducing the related
costs and enhancing the patient experience (Falvey, 2017). These assumptions are
beneficial for launching ACOs, but future research may want to better understand panel
size, patient demographics, and other influential outcome variables (Falvey, 2017).
Risk mitigation treatment (RMT) is a health care providers' ability to render
additional activities to reduce morbidity (Franklin, 2017). These clinical interventions
reducing specific patient risks can make incremental differences but may be subject to
diminishing returns. An example of RMT is care coordination/management for high-risk
demographic groups such as the chronically ill. Franklin used a simulation model design
to test theoretical perspectives on prevention-oriented clinical services. The resulting
finding was analyzed to show a positive correlation between changing payment systems
and significant provider-induced demand changes (Franklin, 2017).
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The declining functional ability of senior patients and the impact on accountable
care costs and quality (Kornuszko-Story, 2018). Conducted via a budget impact analysis
and interviews, potential cost savings and patient function were analyzed. The resulting
indications were that specific facilities could save millions of dollars while the ACO
could reduce discharges and readmissions for further cost savings all while creating a
culture of mobility that would have a positive impact on quality (Kornuszko-Story,
2018).
ACOs and the MSSP
Of all health care payment and delivery systems reforms included in the ACA,
ACOs may have the most significant potential to improve quality and reduce cost
simultaneously. At their core, ACOs embody the pillars of value-based health care
(Perez, 2015). The ACA created a health care industry catalyst with the idea of value
over volume, with providers sharing in Medicare cost savings and focusing on population
health. APMs and care delivery reforms in the United States have increased in popularity
as it relates to their ability to lower health care costs. One of the key components of
success in the program can be attributed to leveraging data for patient care tracking and
service renderings outside of the typical settings. Understanding patient care patterns both
in and out of the ACO network is essential to organizations reducing waste and limiting
unnecessary services. Forward-thinking strategic relationships and innovative
partnerships outside of the ACO, such as those with high-value post-acute facilities,
should be considered to ensure quality performance and to control costs (LaPointe, 2017).
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Table 2
Medicare ACO Strategy
2012
PioneerACO
Model

Advance
Payment
ACO
Model

ACO
Investment
Model
(currently
runs
through
2018)

Medicare
Shared
Savings
Program
(ongoing)

Designed for
*32
experienced
organizations
operating in ACOlike arrangements.
Higher levels and
multiple options of
savings and risk
than the MSSP.
Possible transition
to population-based
payment in year 3.
Upfront advances
and monthly
payments for certain
eligible physicianbased and rural
providers already in
or interested in the
MSSP
Upfront advances
and monthly
payments given on
expected shared
savings for MSSP
ACOs to test prepaid savings in rural
and underserved
areas.
Track 1
Earn up to 50% of
shared savings. No
risk of loss.
Payment capped at
10% of benchmark
Track 1+
Earn up to 50% of
shared savings. Risk

2013

2014

2015

2016

2017

23

20

12

9

No
No
longer longer
active Active

*35

35

35

No
long
active

No
No
longer longer
active active

*45

45

45

412

438

460

*217 399

340

2018

*55
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loss is 30% fixed.
Payment capped at
10% of benchmark
Track 2
Earn up to 60% of
shared savings. Risk
loss is 40%-60%.
Payment capped at
20% of benchmark
Track 3
Earn up to 75% of
shared savings. Risk
loss is 40%-75%.
Payment capped at
20% of benchmark
Next
Earn 80%-100% of
Generation
shard savings.
ACO
Minimum Savings
Model
Rate not utilized.
(currently
Optional Allruns
Inclusive
through
Population-Based
2020)
Payments. Includes
telehealth, 3-day
skilled nursing
facility, and postdischarge home visit
waivers.
Comprehen Multiple options of
sive ESRD
savings and risk.
Care
Designed for EndModel
Stage Renal Disease
(currently
beneficiaries
runs
receiving
dialysis
through
services. First ACO
2020)
with disease specific
focus.
(TXCIN, 2018, para. 3)

#3

3

5

6

6

8

*16

45

58

*13

37

37

*13

37

37
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Table 3
ACO Types and Descriptions
ACO Type
Independent Physician Group
Physician Group Alliance
Expanded Physician Group
Independent Hospital
Hospital Alliance
Full-Spectrum Integrated

Description
A single organization that directly
provides outpatient care.
Multiple organizations that directly
provide outpatient care.
Directly provides outpatient care and
contracts for patient care.
A single organization that directly
provides inpatient care.
Multiple organizations with at least one
that directly provides inpatient care.
All services provided directly by the
ACO. May include one or multiple
organizations.

The CMS intentionally did not provide specific organizational requirements for
MSSP ACOs. As such, current MSSP ACOs consist of academic medical centers,
physicians, hospitals, independent practitioners, multi-specialty groups, Clinically
Integrated provider Networks (CINs), Federally Qualified Health Centers (FQHCs), or a
combination of the aforementioned. As such, the Medicare beneficiary population within
the organizations have diverse demographic and health status patterns. It is not clear
whether the success of MSSP ACOs is due to beneficiary characteristics or that of market
or organizational distinctions. Ouayogode et al. (2017) posited that probable factors for a
MSSP ACO's success include several elements such as beneficiary turnover and
engagement, patient targeting, individual care management plans, evidence-based
medicine, electronic health records, historical spending analysis, and geographic
allocation. To that end, organizational and administrative infrastructure, care
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management proficiencies, and clinical integration are arguably the most important ACO
performance factors.
Accountable Care Initiatives
Powers et al. (2018) noted that ACOs work to control health care spending
effectively; they are a leading player in delivery system reform and value-based payment
models. As their growth will continue regardless of the political party in charge, there is
reason to remain optimistic about the staying power of ACOs. With that, there are some
important implementation lessons to recall when engaging practices in building
Medicare-specific ACOs. Whether smaller in size or independent from hospital
ownership, key factors of practice engagement in value-based care include a dedicated
staff geared toward population health management expertise, practice transformation
strategies, clinical productivity as well as actionable, insightful data sharing, analytics,
and user experience.
The goal of ACOs is to improve the value of health care as soon as possible.
However, it takes time to develop and maintain an infrastructure that is organized enough
to plan, implement, and deploy; strong enough to maintain; and robust enough to scale
outcomes-based care that will overhaul current care processes (Bleser et al., 2019).
Payers that take the proper time, resources, and thoughtful planning to launch
effective value-based care programs can experience overall health care service
improvements over FFS reimbursement. Strong partnerships, provider engagement and
outreach, data sharing, cost management and quality measurement are all critical
components of success in an APM. Properly implemented population health management
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efforts, such as preventive care service offerings as well as quality and utilization
management and review can yield better beneficiary healthcare patterns (Beaton, 2018).
Implementing appropriate strategic health care coordination efforts can improve
transitions of care and allow for reductions in waste, curtail duplication of services, and
galvanize interoperability efforts. Some examples of possible interventions across the
health care continuum include appropriately shifting care from inpatient to lower-cost
outpatient settings, proactive planning for hospital discharges, medication reconciliation,
advancements in health information technology, managing integrated complex care teams
and increasing engagement of beneficiaries and providers (Kaufman et al., 2017).
However, conceptualization, development, implementation, integration, management,
optimization, and transformation look different among various ACO types; stakeholders
undertake performance enhancements differently. Clarification of universally accepted
design and execution strategies could provide important insight into structural successes
(Comfort, 2019).
Data analytics serve an important role in allowing for visualization and actionable
insights of ACO initiatives, results, and potential next steps. Alsleben (2016) posited that
efficiently using healthcare data can increase positive patient outcomes. Proper use of
data analytics allows for more proactive population health management and related
strategy implementation. The technology can engage the care team and provide real-time
suggestions that could positively impact patients at the point of care. Additionally, data
exchange standards and interoperability can be incorporated to further mature the
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collaborative care in sharing and gaining access to information more efficiently and
effectively and in real-time.
Current research notes that integrated networks (such as ACOs) have an
assumptive positive relation on clinical outcomes. Falvey (2017) examined primary care
providers in one integrated health care delivery network (IDN). Linear regression
analyses were performed to analyze a specific subset of disease states; processes, and
IDN outcomes. The study results concluded that proper use of evidence-based clinical
guidelines, as often followed in IDNs, had a positive association with better clinical
quality outcomes, noting the effectiveness of integration.
Integration with other provider types is an important component of ACO success.
Social Determinants of Health (SDOH), Behavioral Health (BH), environmental sciences,
cultural needs, long-term care, and other ancillary service offerings (such as access to
dental, vision, hearing, and transportation needs) impact the managed population’s
overall health (McDonough, 2016). Collaborating with and incorporating the needs of
other health care service offerings assists in addressing a deeper, broader range of patient
care needs and better achieving health outcomes. A focus on the overall quality of care
rendered versus the quantity of services provided is the basis of value-based care
(McDonough, 2016).
Accountable care policies and procedures have administrative, programmatic, and
practical implications. For example, initiatives such as End of Life (EoL) care are
important to the overall success of ACOs. The level of aggressiveness of EoL care as
well as hospice utilization patterns and levels impact an ACO’s outcome measures (Kim,

23
2018). Similarly, Skilled Nursing Facility (SNF) use and related coordination is also an
initiative that could increase overall quality outcomes and financial performance of the
organization (Shipp, 2019). The development of preventive care models for the aging and
chronically ill subpopulations are community and public health imperatives. Advanced
and more mature preventive care models geared toward these subgroups are of growing
importance due to the barriers this specific population faces. Designing, implementing,
monitoring, researching, and improving models related to subpopulations are growing
concerns (Coburn, 2016).
ACO success depends heavily on provider behavior modification. To assure
needed changes, social purpose and professional mastery should be used as two
motivators alongside the financial incentives that are accessible with APM participation.
Positive patient impact, community service, and an opportunity to become a more
effective health care provider by working in a team environment are a few of the factors
that can help stimulate needed changes for provider-related components of U.S. health
care delivery (Phipps-Taylor & Shortell, 2016).
Accountable Care Realizations
MSSP ACOs have shown strong performance related to quality-of-care measures
and have comprehensively yielded cost savings year over year since program inception.
The longer an ACO participates in the MSSP, the more likely the ACO is to be successful
due to significant time and efforts needed on redesign initiatives (Bleser et al., 2018).
Shetty’s (2018) research argues that MSSP ACOs with four or more years of experience
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in the program have a consistent association with reduced spending than peer ACOs with
less experience.
Some crucial strategies in reducing Medicare spending and improving care quality
include efforts such as increasing providers’ awareness of costs, engaging beneficiaries
(particularly those with complex care needs) in improving their own health, reducing
avoidable hospitalizations, better managing SNF, home health, hospice and EoL
initiatives, understanding BH and mental health needs, addressing SDOH, and utilizing
technology to leverage information-sharing among the various participating health care
providers (OIG, 2019).
The DHHS’s Office of Inspector General (OIG) reported that most ACOs had
instituted various strategies that have proven successful in lowering Medicare spending.
Relatedly, the DHHS OIG suggested that CMS should conduct reviews to understand
better the extent to which ACOs are improving quality and reducing spending. For
example, care coordination is a critical component of most ACO’s success in reducing
emergency department (ED) visits and hospital readmissions but sharing this information
more widely, so an increased number of stakeholders become aware, is critical to yield
even more spending reductions and quality improvements amongst ACOs that may need
assistance (King, 2019).
Another important pillar of ACO success is management involvement related to
economies of scale. To increase the effective management of ACOs, care coordination is
critical, but there must be adequate capital for Information Technology (IT)
improvements to be used as a predictor of ACO performance (Lin, 2016). Proper IT
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infrastructure as well as support for data mining, reporting, trending, analyses, and
analytics are important factors for consideration.
From its launch in 2012 through 2018, the MSSP grew to 10.5 million
beneficiaries: a quarter of traditional (or FFS) Medicare. Rooke-Ley et al. (2019)
reviewed that traditional Medicare, revitalized via the MSSP, saves 1.51% per
beneficiary. The Medicare Political Action Committee (MedPAC) agreed, in effect, with
these findings when they concluded that the MSSP saved one to two percent by the year
2016. Some spillover can be accounted for, as well, adding another 0.57 percent to the
overall savings the MSSP has over Medicare Advantage plans.
CMS data shows that 2017 MSSP ACOs saved the federal government hundreds
of millions of U.S. dollars. This number reinforces the fact that ACOs can yield financial
savings if given enough ramp-up time. Also, of importance, is the need to further
strengthen the program for longevity and viability (Sweeney, 2018). From 2013-2016,
MSSP ACOs saved CMS an estimated $2.66 billion (Dobson et al., 2018).
The Journal of the American Medical Association (JAMA) published a study that
found upside only ACOs yielded a $287 million net savings in MSSP ACO performance
year 2014. In like manner, the OIG reported in 2017 that ACOs lowered Medicare
spending by $1 billion during the first three years of the MSSP. The National Association
of ACOs (NAACOs) noted that time, resources, program predictability, experience,
confidence, and some levels of success are all factors needed for ACOs to move toward
two-sided ACO models. ACO-guru, current Aledade Chief Executive Officer (CEO) and
former National Coordinator for Health Information Technology (HIT) in the Obama

26
Administration, Farzad Mostashari, M.D., said that the overarching goal of the MSSP
should not be how many ACOs participate, but how successful those that do participate
are in improving patient care. If providers are going to participate in ACOs, they must be
doing something to add value to the system (Meltzer, 2018).
Shetty (2018) conducted a retrospective cohort study of MSSP ACOs from 20122016 using CMS Public Use File (PUF) data to review overall ACO spending, using a
generalized estimating equation model. Resultantly, findings noted that ACOs who
rendered less primary care services via specialists spent less per capita. The study showed
that in order to reduce spending and perform optimally, ACOs should allow for no more
than 35 to 40 percent of specialists to provide primary care services. The research yielded
that MSSP ACOs with more than two years of experience in the program have lower cost
implications than peer ACOs still in their first year. It is a suggested finding that
participation for several consecutive years is essential for implementing and realizing the
necessary clinical and administrative organizational structure to meet or exceed Medicare
accountable care expectations. Further, MSSP ACOs with four or more years of
consecutive participation show consistently lower expenditures, year over year.
Accountable Care Evolution
In late December 2018, CMS published a final rule for MSSP ACOs to further
promote accountability and competition, changing the program's reference name to
Pathways to Success. For the Medicare Trust Fund (MTF) to see the increased cost
savings needed to ensure the longevity of Medicare entitlement for beneficiaries, there is
an encouragement from the U.S. federal government for MSSP ACOs to transition to
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enhanced risk more quickly, based upon performance. Starting in July 2019, MSSP
ACOs will enter into one of the various tracks with CMS for at least a five-year contract
term (Dealtry, 2019).
Before the evolutionary Pathways to Success update to the MSSP, the program
included three tracks that allowed ACOs to gradually gain experience (sometimes up to
six years with no downside risk to the ACO). No downside risk to the ACO meant that
CMS took on any financial losses that the ACO yielded. While this created a glidepath
for the ACO, it did not mandate the fiduciary responsibility of the ACO to share in the
losses (Leventhal & Landi, 2018).
Pathways to Success is bold in its heightened steps toward quality health care,
lower costs, increased competition, and beneficiary engagement. ACO program
participation is encouraged, but advancement in the transition to value-based health care
and market impact are critical components. As providers further themselves along the
U.S. health care value continuum, expectations for positive outcome are rising (Frieden,
2018).
With the Pathways to Success update, Leventhal and Landi (2018) noted that
CMS is steering away from upside-only models and taking the stand that ACOs should
only have two (versus the aforementioned six) years to progress toward higher levels of
shared financial risk-sharing with CMS. The change is partly because, as of 2019, only
eighteen percent of MSSP ACOs were engaged in downside risk. Ultimately, and as the
CMS administrator, Seema Verma, has made clear, upside only MSSP ACOs do not
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generate enough financial savings and there is, essentially, no real incentive to improve
outcomes and reduce overall health care costs.
As only about 10% of clinicians take on significant levels of financial risk today
in the MSSP, adoption is one of the biggest challenges of advanced APMs. The
transformative path towards value-based U.S. health care is not evolving as quickly as is
needed. The limited, yet sometimes complex nature of APMs and the difficulty in
obtaining actionable, insightful data are just two of the challenges that providers face in
their committed pursuit of ensuring health care value. The Pathways to Success initiative
saw thirty-eight of its applicants apply for advanced APM status risk levels (Leventhal,
2019). Providers interested in population health management relationships with
accompanying financial risk may look to quantify the amount of risk they are willing to
accept while implementing unnecessary service mitigation treatments. Meaning,
providers should weigh the needs of services against the costs of taking on financial risk
with a payer. This utility review may better show provider risk aversion behavior
(Franklin, 2017).
CMS Administrator, Seema Verma, noted that Medicare (and the associated
MTF) is no longer able to support programmatic initiatives with flaccid incentives that do
not deliver the right outcomes. CMS looks to make a significant impact on the overall
health care, specifically Medicare, market. To do so, CMS will continue to appropriately
raise the bar as the MSSP matures to accelerate overall performance (Frieden, 2018).
As MSSP ACOs have expansion goals, there are various recommendations to
ensure advancement of the APMs and effectiveness of accountable care renderings. One
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such recommendation is related to better understanding the education and professional
backgrounds of organizational leaders and essential leadership skills required for
representing diverse population health management needs (Cornell, 2019). Another
recommendation is that of considering the relationship between patient satisfaction,
engagement, and financial performance (Pugh, 2016). Additionally, the best methods of
ACO beneficiary assignment to remain competitive and economically equitable as well
as more balanced risk levels and more attractive incentives are also considerations for
future research (Racca, 2019).
Many positive outcomes of properly implemented ACOs exist while there are
numerous open items related to understanding proper management. One would be remiss
to not mention some of the ethical concerns that arise when ACOs are studied. Westling
(2015) recalled the need for compatible reimbursement models; ensuring one uniform,
proper standard of care; balancing patient choice with financial incentives, respectful
disagreement on best practices, meeting ACO metrics versus evidence-based measures,
as well as ensuring proper resources for preventive and reactive services as potential
conflicts of ethical interest. ACO administrators and clinicians must keep these thoughts
in mind when developing initiatives and planning for resources such as people, processes,
and technology. Westling’s research identified several major ethical issues that fell under
biomedical principal domains such as justice, autonomy, beneficence, and nonmaleficence. The research method Westling used was that of semi-structured, open-ended
surveys. The overarching ethical issues included (a) under treatment due to financial
reasons, (b) breaches of patient confidentiality, (c) lack of financial disclosures and (d)
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overuse of practice guidelines. The findings were conflicting, but ultimately found that
most providers will do what is in their patient's best interest. The only finding with a
potential mitigation effect was that of shifting resources to be prevention focused.
Alibrahim (2017) wrote on the importance of continuous evaluation and review of
initiatives as the U.S. health care market evolves around regulations, antitrust, privacy
and other related matters. The market’s ever-changing dynamics impact the powers,
players, behaviors, and outcomes of ACOs. Provider capacity and service options are
differentiating factors that can be leveraged to tip the competitive balance of ACOs. Case
(2015) affirmed the need for health policy and delivery education programs for clinicians
and administrators to improve their engagement levels and generate ideas for achieving
efficient high-quality, lower cost U.S. health care.
Accountable Care Total Savings/Losses, Quality Score and Total Assigned
Beneficiaries
Falk (2016) examined the 2014 performance data of Track 1 MSSP ACOs, using
a quantitative analysis. The research findings included that ACOs further along in the
contractual continuum of MSSP participation were more likely than younger, less mature
ACOs to achieve savings; due partially to the learning curve, but also due to realized
returns on initial investments in care coordination and preventative care initiatives. Falk
(2016) noted there were numerous correlated data elements that showed statistical
significance as it relates to overall success (generating savings) of the ACO, but there is
however, still a need for additional research on future years’ ACO data to note the
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relationship that MSSP ACO participation can have on overarching costs and quality as it
relates to the beneficiary (or managed population) pool.
Lin (2016) reviewed 2012, 2013, 2014 and 2015 MSSP ACO cohorts’
performance. The methodology used was quantitative analysis of secondary data using
multiple logistic and linear regressions. The study was a survey with 61 ACO
executive/manager respondents yielding various responses about their respective ACO’s
performance and related perceptions of hospital involvement, degree of information
technology adoption and usage as well as integration.
Noting the current lack of adequate research studies and information related to
current MSSP ACO performance, specifically germane to beneficiaries, cost, and quality;
there is a need for the review of the 2018 performance year MSSPACOs as it relates
particularly to Generated Total Savings/Losses, Quality Score and Total Assigned
Beneficiaries.
Definitions
Accountable Care Organization (ACO): A legal entity formed by one or more
ACO participants (Title 42 – Public Health, 2018).
ACO participant: An entity enrolled in Medicare that composes an ACO (Title 42
– Public Health, 2018).
Assignable beneficiary: A Medicare FFS beneficiary who, within a certain oneyear period, sought primary health care services from a Medicare enrolled Doctor of
Medicine (M.D.) or Doctor of Osteopathy (D.O.; Title 42 – Public Health, 2018).
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Assignment: A CMS operational process of noting previous primary health care
services from an ACO participant to appropriately designate a general beneficiary
responsibility upon participant for a set performance year (Title 42 – Public Health,
2018).
Assignment window: The one-year period whereby beneficiaries are assigned to
an ACO. Medicare FFS Beneficiary is a person who is enrolled in traditional Medicare
(not a Medicare Advantage plan) for parts A and B (Title 42 – Public Health, 2018).
(Gross) Generated losses: Total losses (measured as Benchmark Minus Assigned
Expenditures, from first to last dollar) ACOs in Track 2, Track 3, or the Track 1+ Model
whose losses rate equaled or exceeded their MLR. This amount does not account for the
application of the ACO’s final sharing rate based on quality performance (for Track 2 or
3 ACOs) or the loss sharing limit (CMS, 2020).
(Gross) Generated savings: Total savings (measured as Benchmark Minus
Expenditures, from first to last dollar) for ACOs whose savings rate equaled or exceeded
their MSR. This amount does not account for the application of the ACO’s final sharing
rate based on quality performance, reduction due to sequestration, application of
performance payment limit or repayment of advance payments (CMS, 2020).
Medical loss ratio (MLR): Money spent on premium dollars versus that spent on
overhead activities. If an insurer uses eighty percent of premium dollars to pay claims
and ensure quality improvement activities, the insurer is said to have a MLR of eighty
percent if they spend the remaining twenty percent on overhead. The ACA set varying
MLRs in different markets (healthcare.gov, 2020).
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Minimum savings rate (MSR): A respective percentage of an ACO’s historical
benchmark, updated and calculated based on the population size of the assigned
beneficiary pool (healthcare.gov, 2020).
Medicare Shared Savings Program (Shared Savings Program) One-Sided Model:
One whereby the participating ACO shares the savings with the CMS program if certain
requirements are met. This model does not create liability for the ACO to share in any
financial losses (Title 42 – Public Health, 2018).
Medicare Shared Savings Program (Shared Savings Program) Two-Sided Model:
one whereby the participating ACO shares in any potential savings and is also liable for
sharing in any potential financial losses (Title 42 – Public Health, 2018).
Performance year and reporting period: Generally, the 12 months beginning on
the first of January each year, unless otherwise noted (Title 42 – Public Health, 2018).
Quality measures: Assess the quality of care that an ACO renders, inclusive of
clinical outcomes (Title 42 – Public Health, 2018).
Quality score: In Performance Year 1 of an ACO’s first agreement period, the
quality score is 100% if all measures were completely reported and less than 100% if one
or more measures were not completely reported. Beyond Performance Year 1 of an
ACO’s first agreement period, the quality score will be determined not only by whether
all measures were completely reported but also on their performance against established
benchmarks and on quality improvement. For ACOs determined to have been affected by
a natural disaster, the quality score is the higher of the ACO's calculated initial quality
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score or the national mean quality score across all Shared Savings Program ACOs who
met the quality performance standard (CMS, 2020).
Total assigned beneficiaries: The total number of beneficiaries assigned to an
ACO in a particular performance year (CMS, 2020).
Assumptions
The aspects of this study believed to be true were that the participating ACOs
understand what population health is, what their basic principles are, what the goals of
the MSSP are and how to ensure objectives are met. Additionally, it is assumptive that
each ACO knows the MSSP ACO performance rules, guidelines, and factors that impact
advanced APMs. These assumptions are of critical importance as ACOs participate in the
MSSP and are necessary in the context of the study due to the need to manage an entire
population (at least five thousand attributed, assigned Medicare beneficiaries). Moreover,
it is assumed that MSSP ACOs know their organization signed up to be accountable for
the overall care of their patient population, must coordinate care with various health care
teams, invest in infrastructure, and work toward redesigning health care to ensure highly
efficient and quality service delivery (Physicians Advocacy Institute, 2020).
Scope and Delimitations
The scope of the study was inclusive of 2018 MSSP ACO results related to
Generated Total Savings/Losses, Quality Score, and Total Assigned Beneficiaries. The
specific aspects of the research problem addressed in the study were the costs, quality and
total assigned beneficiaries of 2018 MSSP ACO participants. The specific focus chosen
was because 2018 was the most recent publicly shared data file at the time this study was
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initiated. As ACOs participate in the more recent years’ MSSPs, and as years’ worth of
value-based health care progresses in the U.S., the understanding of population health
should be relatively mature, the organizations should be evolved, and it is arguable that
transformation should be able to be properly managed in terms of the people, processes,
and technology required.
The boundaries of the study included MSSP ACO participants that have served
various evaluation and management (E&M) services to at least 5,000 Medicare FFS
beneficiaries and have a contract with CMS for at least three years. MSSP ACOs could
include ACO professionals (physicians, physician assistants, or nurses) in group
arrangements, networks of individual practices working together, partnerships or joint
ventures, hospitals, FQHCs, and/or Rural Health Clinics (RHCs). The Medicare
beneficiaries are attributed to the MSSP ACOs through a prospective methodology based
on historical claims data, actual plural utilization during the performance year or
preliminary assignment, or voluntary alignment (Physicians Advocacy Institute, 2020).
This study did not include products or populations that are outside of MSSP ACO
parameters such as commercial, Medicare Advantage (M.A.), Medicaid, CHIP, ACA
Individual Exchange, and/or Veterans Affairs (V.A.) health plans and managed care
organizations.
Theories related to this study, but were not fully investigated herein include, but
are not limited to, the ACO Logic Model, Resource Dependency Theory, Structural
Contingency Theory and Transaction Cost Economics (Palazzolo, 2015). The potential
for generalizability was considered, but well understood that Medicare beneficiaries are
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not all treated equitably in terms of accountable care service renderings and outcomesbased measurement amongst different providers, across various programs in disparate
geographies.
The limitations of this work included data, analysis, and trending reports that are
provided by the U.S. federal government and engaged, interested or participating
organizations of MSSPs for the years of implementation, participation, and reporting.
Therefore, the findings in terms of the relationship between Quality Score, Generated
Total Savings/Losses and Total Assigned Beneficiaries cannot be representative of the
entire U.S. health care system nor even all the Medicare-eligible population (as a large
percentage of beneficiaries participate in a M.A. plan and some participate in none) and
does not compare MSSP ACOs to non MSSPs ACO that may also be generating a higher
value for the same variables of this study. While the Medicare FFS program showed that
certain MSSP ACOs have generated savings for that specific sector of the population, it
does not negate the fact that the entire system’s cost could still be increasing, and quality
could still be declining.
The challenges that arise when one attempts to review a relatively new program in
a dynamic environment in an evolving, ever-changing system are that things do not
remain static. It is difficult to ensure sound statistical analysis when there are frequent
changes, year-over-year to the quality measures, or the cost-savings factors. Systematic
and technical adjustments, as well as re-alignment, must be made by providers that may
cause indifferent results. It is arduous to measure certain quality metrics when there are
so many outlying issues that can affect the result. One must review data and reasoning
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but understand there are retrospective changes that occur as well as arguments to a
methodology that make sense in the space that must be considered.
The barriers one stands against when reviewing MSSP ACO quality measure data
is the difficulty (or near impossibility) with extracting the effects that other Medicare
changes and regulations have on the MSSP. For example, changes in Medicare rules
regarding inpatient days, bundled payments for services such as total knee replacements,
and other advents geared toward ensuring proper care across all provider types can and
will very likely have a compounding, comprehensive effect on other initiatives being
studied, such as MSSP ACOs. This is beyond the scope of this work but is a means for
future study.
Significance, Summary, and Conclusions
This study contributed to a better understanding of the potential relationship
between Generated Total Savings/Losses, Quality Score and Total Assigned
Beneficiaries within 2018 MSSP ACOs. A scholarly review of the public use data file for
2018 validated Medicare Generated Total Savings/Losses and Quality Score advances as
it relates to Total Assigned Beneficiaries (CMS, 2018). This is meaningful to the system
in a multitude of ways. As previously reviewed in this study and as Falk (2016) noted,
research performed on future years’ MSSP ACO data (such as performance year 2018) is
needed to relay the relationship amongst variables such as those studied in this work.
The bequest to the health services administration discipline, and the practice of
health care in general, that this study will make is presenting to the reader the realities of
statistically significant relationships among Quality Score, Generated Total
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Savings/Losses and Total Assigned Beneficiaries in a specific MSSP ACO performance
year. The relationship is important to understand in noting how organized, accountable
health care, rendered in a quality-oriented, cost-aware state may qualitatively be
considered a foremost option for overall medical and administrative cost savings
concurrently boosting quality metrics, specifically in the Medicare space; replicable in
other sectors of the system, but may or may not reflect same in a quantitative way. The
research looks to support the professional practice of health care, in general, and
demonstrate practical application by presenting select 2018 performance year data to
review if MSSP ACOs should be considered an avenue of which can be utilized to reach
the overarching U.S. health care system goals of achieving better care for individuals and
better health for populations while lowering the growth in expenditures (National
Association of ACOs, 2018).
MSSP ACOs that have shown success in meeting quality indicator benchmarks
and cost savings have a series of strategies that they have followed, including, but not
limited to care management, transitions of care administration, varying use of health IT,
and improved processes (Mostashari & Broome, 2016). It is significantly relevant that the
MSSP arrangement launched under the ACA to reduce spending and improve quality of
care, among other objectives, is working. ACOs have resulted in favorable Medicare cost
and quality performance (Livingston, 2017). The remaining question for enveloping U.S.
health care lies in just how deep, broad, and far-reaching the effects of MSSP ACOs can
be to the systemic structure. Interested parties look to better understand how the
organizations will lead to positive social change for health care stakeholders of all kinds:
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patients, providers, public payers, private constituents, policymakers, researchers, and the
like. If MSSP ACOs can continue to decrease health care costs while concurrently
increasing quality for managed populations, there is a compelling argument for their
staying power in the U.S. health care system. If able to maintain momentum and prove
transformative, MSSP ACOs could forever change the health care landscape.
Section 1 provided the problem statement, purpose of the study, research
questions and related hypotheses, theoretical foundation, nature of the study, literature
review, definitions assumptions, scope, delimitations, and significance. Section 2 will
review the research design and rationale, analysis methodologies, threats to validity and
ethical procedures. Section 2 will review the research design and rationale, methodology,
threats to validity, as well as ethical procedures.
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Section 2: Research Design and Data Collection
The purpose of this quantitative study was to note the statistically significant
relationship between Quality Score, Generated Total Savings/Losses, and Total Assigned
Beneficiaries for MSSP ACO participants in the 2018 performance year. The literature
review yielded findings that MSSP ACOs are a viable option for health administrators to
reach systemic goals due to their effect on cost and quality; they can not only save the
federal government billions of dollars as the years progress and initiatives become more
innovative and collaborative, but also ensure care quality is enhanced (National
Association of ACOs, 2018). The need for my study lay in noting whether MSSP ACOs
can improve quality and costs savings to allow further expansion of ACOs by health
administrators by reviewing the relationship between 2018 MSSP ACOs’ Quality Score,
Generated Total Savings/Losses and Total Assigned Beneficiaries.
The major sections of this chapter include Research Design and Rationale,
Methodology (population, sampling, and instrumentation/operationalization), and Threats
to Validity (including Ethical Procedures).
Research Design and Rationale
The study’s variables were Generated Total Savings/Losses, Quality Score and
Total Assigned Beneficiaries. For Research Question 1, the independent (X, horizontal
line) score, predictor variable was Quality Score and the dependent (Y, vertical line)
score variable was Generated Total Savings/Losses. The independent and dependent
variables were both scale variables; therefore, the analysis performed was a simple linear
regression. For Research Question 2, the independent (X) variable was Total Assigned
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Beneficiaries, and the dependent (Y) variable was Quality Score. The independent and
dependent variables were both scale variables; therefore, the analysis performed was also
a simple linear regression.
The research design was nonexperimental using secondary data quantitative
analysis. Nonexperimental design does not manipulate the variables studied; it is used in
research when there are specific research questions or hypotheses about correlations
amongst variables (Mehl et al., 2007). Nonexperimental design was applied to this study
because I used a PUF, whereby the variables were studied, not manipulated in any way,
and I hypothesized what the relationships were among the independent and dependent
variables. The methodology of inquiry was a systematic review and strategic analysis of
said publicly available secondary data for MSSP ACO participants in the 2018
performance year. The connection of the research design to the research questions aligns
as the secondary data allowed me to note the relationship between Quality Score to
Generated Total Savings/Losses and Quality Score to Total Assigned Beneficiaries.
The time constraint of this study was that the only ACO performance year to be
studied was 2018. Only the 2018 MSSP ACO performance year was studied because it
was the most current MSSP ACO PUF data shared at the time of doctoral study initiation
and allowed me to review Quality Score, Generated Total Savings/Losses, and Total
Assigned Beneficiaries data for the most recent year of MSSP ACO participation, at the
time.
Resource constraints consisted of the fact that the research only reviewed CMS
MSSP ACO PUF data available via the internet on CMS’s website. Other sources of data
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that could have been used in this study, but were not, include Medicare Hospital Compare
Data, Agency for Healthcare Research and Quality (AHRQ) information, National
Committee for Quality Assurance (NCQA) quality indicators, and other CMS as well as
private payer ACO data.
Additional factors that this study could have included, but did not, were whether
MSSP ACOs were a part of other pay-for-performance, value-based, outcomes-based
quality improvement, APM and/or cost savings initiatives with other payers for
commercial, M.A. Medicaid, Children’s Health Insurance Program (CHIP), Exchange,
V.A., or other lines of business.
This study did not take into account whether the reviewed 2018 MSSP ACO
participants engaged in any other CMS healthcare transformation efforts under
accountable care (e.g., the Comprehensive End-Stage Renal Disease Care Model, the
Medicare Health Care Quality Demonstration and the Vermont All-Payer ACO Model),
episode-based payment initiatives (e.g., Bundled Payments for Care Improvement
Initiative, Comprehensive Care for Joint Replacement Model and Oncology Care Model),
nor primary care transformation (e.g., Comprehensive Primary Care Plus, Independence
at Home Demonstration and Primary Care First Model).
Also not accounted for in this study was whether 2018 MSSP ACO participants
were a part of other CMS initiatives focused on the Medicaid and CHIP population (e.g.,
Medicaid Innovation Accelerator Program, Financial Alignment Initiative for MedicareMedicaid Enrollees, and Initiative to Reduce Avoidable Hospitalizations Among Nursing
Facility Residents).
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Initiatives to accelerate the development and testing of new payment and service
delivery models (such as Accountable Health Communities Model, Artificial Intelligence
Health Outcomes Challenge, CMS Innovation Center New Direction, Emergency Triage,
Treat and Transport Model, Home Health Value-Based Purchasing Model, Maryland AllPayer Model, Maryland Total Cost of Care Model, MA, Value-Base Insurance Design
Model, Medicare Care Choices Model, Pennsylvania Rural Health Model, Regional
Budget Payment Concept, Rural Community Hospital Demonstration, State Innovation
Models Initiative and Value in Opioid Use Disorder Treatment Demonstration Program)
were also not noted in this study.
Initiatives to speed the adoption of best practices (such as the Health Care
Payment Learning and Action Network, Hispanic Health Services Research Grant
Program, Historically Black Colleges and Universities Research Grant Program,
Medicare Diabetes Prevention Program Expanded Model, Million Hearts and Partnership
for Patients) were not specifically reviewed in this study to note whether MSSP ACO
participants partook in those efforts or not.
The design choice of nonexperimental secondary data analysis, whereby CMS
2018 MSSO ACP PUF data were reviewed to understand the relationship between
Generated Total Savings/Losses, Quality Score and Total Assigned Beneficiaries for the
participants in the 2018 performance year, was consistent with the need to advance
knowledge of MSSP ACO overall performance in the most mature year since inception
of the program to compare various metrics for correlations.
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Generated Total Savings/Losses were the total savings or losses that the
participating MSSP ACOs renders for their patient population; ultimately–whether the
ACO spent less money than benchmarked in the performance year, or more. Quality
score was originally measured as 100% if all measures were completely reported and less
than 100% if one or more measures were not completely reported. Afterward, quality will
be determined by whether measures were completely reported and the performance
against established benchmarks and improvement efforts. Total Assigned Beneficiaries
were the total number of Medicare beneficiaries that each ACO had attributed to the
group.
I used the CMS’s MSSP ACO 2018 Public Use Files as the source of data. At the
time of writing, the information could be found on CMS’ website.
Methodology
Population
The population included in this study were the 2018 MSSP ACO provider
participants and their related managed beneficiary pool. As of the first day in January of
the 2018 performance year, there were 561 ACOs (the most out of all performance years,
2012 to current) in all fifty states plus Washington, DC, and Puerto Rico. The 10.5
million assigned Medicare beneficiaries in the year 2018 was the second highest of all
MSSP ACO performance years, 2012 to current. $983 million was the total earned shared
savings (the most out of all performance years, 2012 to current). There was a reported
93% average overall quality score (second highest to 2016’s and 2012/2013’s 95%). In
the 2018 performance year, there were 171 physician-only ACOs (30%, 324 physicians,
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hospitals and other facilities ACOs (58%), and 66 FQHCs/RHCs ACOs (12%). The 2018
Medicare beneficiary demographic distribution was as follows:
•

ESRD – 81,397 (0.79%)

•

Disabled – 1,294,555 (12.64%)

•

Aged Dual – 688, 076 (6.72%)

•

Aged Non-Dual – 8,180, 954 (79.85%; CMS, 2019)

Sampling and Sampling Procedures Used
The population included the comprehensive MSSP ACO 2018 performance data
set. The sample for sensitivity analysis was determined by a G*Power Analysis. The
procedure used to collect the secondary quantitative data consisted of visiting the CMS’s
MSSP ACO PUF government website (https://www.cms.gov/Research-Statistics-Dataand-Systems/Downloadable-Public-Use-Files/SSPACO), clicking on the 2018 Shared
Savings Program ACO interactive data set and opening the associated next page. Then, I
exported the standard analytical data file into an Excel workbook. Once the Excel
workbook was open, I filtered columns to only see column B (ACO_Name), column S
(N_AB), column W (GenSaveLoss) and column AB (QualScore) to make the data set
easier to analyze for the linear regressions that were performed. The dataset showed a
total of 548 participating ACOs with associated variables. As noted earlier in this study,
N_AB is the variable name for Total Assigned Beneficiaries, GenSaveLoss is the
variable name for Generated Total Savings/Losses and QualScore is the variable name
for Quality Score.
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As noted in this work, RQ1 asked, Is there a statistically significant relationship
between the Quality Score and Generated Total Savings/Losses for 2018 Medicare
Shared Savings Program Accountable Care Organization participants? The null
hypothesis for RQ1 stated there is no statistically significant relationship between the
Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings
Program Accountable Care Organization participants. The alternative hypothesis for RQ1
stated there is a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants. RQ2 asked, Is there a statistically significant
relationship between the Quality Score and Total Assigned Beneficiaries for 2018
Medicare Shared Savings Program Accountable Care Organization participants? The null
hypothesis for RQ2 stated there is no statistically significant relationship between the
Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings
Program Accountable Care Organization participants. The alternative hypothesis for RQ2
stated there is a statistically significant relationship between the Quality Score and Total
Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable Care
Organization participants. RQ1’s independent variable is Quality Score. RQ1’s
dependent variable is Generated Total Savings/Losses. RQ2’s independent variable is
Total Assigned Beneficiaries. RQ2’s dependent variable is Quality Score.
I ran a preliminary sensitivity analysis via G*Power (Version 3.1.9.6 for Mac OS
X 10.7 to 10.15; 2 MB) software. This preliminary sensitivity analysis was run to better
understand certain elements and the minimum sample size needed for the comprehensive
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data analysis. The protocol of power analyses via G*Power included an F test, using the
statistical test of linear multiple regression: fixed model, R2 deviation from zero. The type
of power analysis was a priori, used to compute required sample size – given alpha,
power and effect size. The input parameters determined a 0.15 effect size f2, 0.05 alpha
err prob, 0.8 power (1-beta err prob), and the total number of predictors as 1. The output
parameters determined an 8.2500000 noncentrality parameter, 4.0230170 critical F, 1
numerator df, 53 denominator df, 55 total (minimum) sample size and 0.8050826 actual
power.
Instrumentation and Operationalization of Constructs
This study used a published instrument developed by the CMS, with associated
data published in 2019 and made publicly available on the CMS’ government website.
The study reviewed the MSSP ACO 2018 performance year. This instrumentation was
appropriate to the study because it was used to note the relationship between the variables
chosen for review. Permission was not required from the developer (the CMS) because it
was a U.S. government-supplied data file created for public consumption and use.
However, an emailed permission letter (see Appendix) was exchanged between the CMS
and scholar practitioner that confirms permission and use for this doctoral study. The
reliability of the published instrument was high because it yielded the same results
regardless of the researcher using the federally shared PUF data set. The validity of the
published instrument has been argued by various interested parties due to the fact the data
set cannot predict counterfactual scenarios. Specifically, it is hard to know what would
have been spent on CMS covered benefits for the population served if ACOs did not exist

48
(LaPointe, 2017). This instrument was previously used in performance years 2012, 2013,
2014, 2016, and 2017 with the same Medicare population, but with slightly different
measures and modes of interpretation. The instrument is planned to be used in future
performance years, as well.
Operationalization
All variables in this study had numerical values. The operational definition of
Total Assigned Beneficiaries, Quality Score and Generated Total Savings/Losses was
noted earlier in this work. In summary, N_AB was the variable name for Total Assigned
Beneficiaries, GenSaveLoss was the variable name for Generated Total Savings/Losses
and QualScore was the variable name for Quality Score. The description of Total
Assigned Beneficiaries is the total number of assigned beneficiaries in the performance
year. The description of Generated Total Savings/Losses is total savings for ACOs whose
savings rate equaled or exceeded their MSR or total losses for ACOs whose loss rate
equaled or exceeded their MLR. The description of Quality Score varies depending on
performance year and agreement period. In the initial performance year of an ACO’s first
agreement period, the Quality Score is automatically 100% if all measures were
completely reported and less than 100% if one or more measures were not completely
reported. After the initial performance year of an ACO’s first agreement period, the
Quality Score will be determined by whether all measures were completely reported as
well as the ACO’s performance against established benchmarks and on quality
improvement. There is assistance in quality scoring for ACOs affected by natural
disasters. (CMS, 2020).
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As previously stated earlier in this study:
•

The IV for RQ1 was Quality Score

•

The DV for RQ1 was General Total Savings/Losses

•

The IV for RQ2 was Total Assigned Beneficiaries

•

The DV for RQ2 was Quality Score

CMS uses prospective and retrospective beneficiary assignment for Tracks 1 and
2. CMS uses prospective beneficiary assignment only for Tracks 1+ and 3. If a
beneficiary receives at least one service from a primary care provider within that ACO,
the beneficiary is assigned via a two-step process. Additionally, in the 2018 performance
year, beneficiaries could self-designate via voluntary alignment through MyMedicare.gov
(CMS, 2020). The operational definitions of the variables were described in the Purpose
of the Study section of this work.
Data Analysis Plan
Software used for initial analysis of the data was G*Power. G*Power is a
statistical software used to calculate data analyses and related powers. Additional
software used was that of IBM’s Statistical Package for the Social Sciences (SPSS). IBM
SPSS is a statistical package utilized for interactive analyses. The researcher performed
an initial G*Power analysis to determine the minimum needed sample size and address
the elements to be reviewed in the data set. Data cleaning and screening procedures were
reviewed by a quantitative methodologist, as appropriate. As noted previously in this
work, the first research question noted if there is a statistically significant relationship
between the Quality Score and Generated Total Savings/Losses for 2018 Medicare
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Shared Savings Program Accountable Care Organization participants and the second
research question noted if there is a statistically significant relationship between the
Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings
Program Accountable Care Organization participants.
The analysis plan was inclusive of statistical tests, procedures, rationale, and
interpreted results. The statistical tests that were used to test the hypotheses included
simple linear regression of scale variables and ANOVA Analysis. The procedures used to
account for two different statistical analyses were appropriate because of the two research
questions and their differing independent and dependent variables. There were no
covariates nor confounding variables. Results were reported (key parameter estimates,
confidence intervals or probability values, odds ratios, etc.) by using the SPSS software
tool.
Threats to Validity
The threats to external validity could have been potential interaction effects and
reactiveness of arrangements. For example, if MSSP ACO participants engaged in
multiple value-based care efforts, each requiring different initiatives to be worked on
with various benchmarks and scoring mechanisms, there could have been confusion as to
when and where to allocate particular practice protocols; how to properly manage the
practice from an administrative and clinical perspective and when/if to treat certain
members differently based on their associated payer. In contrast, a MSSP ACO
participant could have been managing value-based care efforts for an attributed, assigned
population and providing FFS health care needs. At the same time, though, if all patients
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were treated with equitable health care consistencies in mind, providers might have
reacted differently when rendering care to a FFS patient versus that of an outcomes-based
one. This phenomenon of FFS volume versus value-based care provision could have
negative or positive implications on the overall total patient population that the MSSP
ACO provider participant oversaw. It is important to recognize the external threats in this
study because although MSSP ACO participation was studied as a move in the right
direction toward value-based health care in the U.S., there remains the above-stated
extraneous factors that convolute that notion.
The study’s threats to internal validity may have included program participation
maturity, experimental mortality, and selection interaction. For example, if a MSSP ACO
participant was aware of their participation requirements, understood the quality
indicators and shared savings (cost) guidelines, but for whatever reason were not aligning
with the organizational evolution, transformation, and reengineering required to meet
value-based care needs, there may have existed a discord with the intent of the program.
The more time that a provider remains participating in a MSSP ACO, the more mature
the opportunity for advancement along the continuum. However, if practice
administration and clinical refinement were not occurring and sophistication was lacking,
therein could lie a problem with the move towards value-based health care. There could
also have been an issue with providers not owning enough of the risk in their
performance-based contractual agreement; meaning, there was not enough provider
support as the practitioner did not have financial consequences as it relates to cost and
quality indicators (Mostashari, 2018).
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Ethical Procedures
This study used CMS MSSP ACO PUF data. Public use files are allowed by the
CMS to be used where and when appropriate, by any public interested party. The
researcher, however, did submit an electronic mail communication whereby permission
was granted from the CMS for the researcher to use PUF data, noting that the public can
utilize it for various purposes (inclusive of doctoral studies such as this). There will be no
human participant (in this case, for example, Medicare beneficiaries nor MSSP ACO
participating providers) specific detail provided in the PUF. There were no institutional
permissions that needed to be granted to use the CMS’ MSSP ACO PUF data, thus none
were obtained.
Ethical concerns as it relates to recruitment materials and processes were not
applicable at the person/member level for this study. From a business perspective, the
MSSP ACO participating provider groups agreed in their CMS contract to publish their
entity and performance information as it relates to the scores and benchmarks for their
MSSP ACO participation in the applicable performance year (CMS, 2019). As the MSSP
ACO participants had a contract in place, at the time, with CMS to relay the guidelines
for participation in the program, there were no ethical concerns in this study related to
data collection regarding MSSP ACO participants refusing to participate or requesting
early withdrawal.
The study data were taken from a federal government source, published for
utilization by interested parties as a “Public Use File” posted on the CMS website.
Although the data are public, permission to gain access to the secondary data set and
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subsequent use in doctoral research was obtained from CMS. See Appendix A:
Permission to Use CMS MSSP ACO PUF data. The public data used for this study were
found and remains archived on the CMS website where the PUF data sets are housed.
The data did not contain any sensitive or non-public information at the time of use. The
CMS are the stewards of the data that was used in this secondary data analysis doctoral
study.
In terms of ethical implications, this study had no understood entanglements. The
researcher used a public use file for the data analysis and received permission to use from
the source. Secondly, the matter of privacy or confidentiality was overruled when it came
to participating provider groups because each participant was fully aware of and agreed
to allow their performance to be publicly available at the time. Insofar as Medicare
beneficiary-specific detail, that remained privy to the data collection mechanism that
CMS used to collect MSSP ACO details; not available via the PUF utilized for this study.
Summary
The research design of this study was non-experimental using secondary data
quantitative analysis of a CMS public use data file. The methodology of inquiry consisted
of a systematic review and strategic analysis of said publicly available secondary data for
MSSP ACO participants in the 2018 performance year. The study noted that the 2018
MSSP ACO performance year had the most participants, the most total earned shared
savings and the second highest average overall Quality Score of all years, to date
(Centers for Medicare & Medicaid Services, 2019).
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Sullivan and Feore (2018) noted a recent analysis finding that the more
experience MSSP ACOs have, the more likely they are to generate savings. The longer
individual ACOs participate in the MSSP, the broader the shift away from FFS models
become. Year-over-year participation in a MSSP ACO allows for more experience with
population health management, creation, and implementation of data infrastructure(s),
and changing behavior to render positive financial results and quality indicators.
Section 2 provided the research design and rationale, analysis methodologies,
threats to validity and ethical procedures. Section 3 will review the collection of
secondary data.
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Section 3: Presentation of the Results and Findings
The purpose of this quantitative study, and a differentiator from others published,
was to note the statistically significant relationship between quality and costs as well as
the statistically significant relationship between quality and the assigned beneficiaries for
MSSP ACO participants in the 2018 performance year. The literature review revealed
that MSSP ACOs are a viable option for health administrators to reach systemic goals
due to their effect on cost and quality; they can not only save the federal government,
revenue via taxpayers, billions of dollars as years progress and initiatives become more
innovative and collaborative, but also ensure care quality is enhanced (National
Association of ACOs, 2018). This study was needed to determine whether MSSP ACOs
can improve quality and costs savings as it relates to assigned beneficiaries to allow
further expansion of ACOs by health administrators.
The research questions and hypotheses, as presented previously in this study, are
noted below:
RQ1: Is there a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants?
H01: There is no statistically significant relationship between the Quality Score
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
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H11: There is a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
RQ2: Is there a statistically significant relationship between the Quality Score and
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable
Care Organization participants?
H02: There is no statistically significant relationship between the Quality Score
and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
H12: There is a statistically significant relationship between the Quality Score and
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable
Care Organization participants.
RQ1’s independent variable is Quality Score. RQ1’s dependent variable is
Generated Total Savings/Losses. RQ2’s independent variable is Total Assigned
Beneficiaries. RQ2’s dependent variable is Quality Score.
Generated total savings are the gross total savings for ACOs whose savings rates
were equal to or less than their MSR. Generated total losses are the gross total losses for
Track 2 and 3 ACOs whose savings rates were less than or equal to their MLR. ACO
Tracks (inclusive of 2, starting in 2012 and 3, starting in 2016) vary in financial
structures, beneficiaries, data and quality reporting requirements, compliance, and
waivers. Quality Score was 100% in the ACO’s first agreement period if all measures
were completely reported and less than 100% if one or more measures were not
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completely reported. Medicare requires ACOs to report the quality measures, which are
composed of 33 nationally recognized measurements in four categories (i.e., patient
experience, care coordination/patient safety, and preventative health) and five different
at-risk populations. Afterward, the Quality Score is determined by whether measures
were completed reported or not and on the ACO’s performance against certain quality
improvement initiatives and established benchmarks (CMS, 2018).
This section reviews the data collection process using a secondary data set, data
analysis results, and the summary of findings.
Data Collection of Secondary Data Set
I used the CMS’s 2018 Medicare Shared Savings Program Accountable Care
Organizations Public Use File data (and associated dictionary) as the data source for this
study. The files were found on the CMS site (https://www.cms.gov/Research-StatisticsData-and-Systems/Downloadable-Public-Use-Files/SSPACO/index.html). The data
document was titled
“2018_Shared_Savings_Program_SSP_Accountable_Care_Organizations_ACO_PUF.”
The dictionary document was titled “Dictionary.ACO.SSP.PUF.2018” (CMS, 2018).
The time frame for data collection was inclusive of the 2018 performance year. I
did not have to complete any recruitment efforts nor be concerned with response rates as
the secondary data set was managed by the CMS’ 2018 MSSP ACO participants. There
were no discrepancies in using the secondary data set from the plan presented in Section
2 of this work.
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The baseline descriptive and demographic characteristics of the sample included
Generated Total Savings/Losses (noted as GenSaveLoss in the dataset), Quality Score
(noted as QualScore in the dataset) and Total Assigned Beneficiaries (noted as N_AB in
the dataset). The sample represented the population of interest having included 548
participating MSSP ACOs in the 2018 MSSP ACO performance year.
The statistical assessment used to test the hypotheses for both RQs was simple
linear regression of scale variables. The procedures used to account for two different
statistical analyses were appropriate because of the two research questions and their
differing independent and dependent variables. There was no basic univariate analysis,
covariates, nor confounding variables. Once SPSS was opened, I used the analyze option
to review descriptive statistics then frequencies to create tables in the software, presented
herein.
The Results
Descriptive statistics and related data visualizations were reviewed for the three
variables included in RQ1 and RQ2 with a total population of 548. The Mean (average)
of Quality Score was 0.929064. The mean of Total Assigned Beneficiaries was
18,424.95. The mean of Generated Total Savings/Losses ($) was 2,850,592.38. These
statistics of the average participating 2018 MSSP ACO note a Quality Score of nearly 1,
Total Assigned Beneficiaries of just over 18,000 and Generated Total Savings of almost
$3 million. The findings show the analyst and interested parties that the 2018 MSSP
ACO participating providers were, on average, mostly high quality with shared savings,
managing nearly 20,000 beneficiaries. The relevance lies in the fact that one could note
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overarchingly that 2018 MSSP ACO participating providers rendered high quality care in
a cost-effective manner for many beneficiaries.
The median for Quality Score was 0.937650. The median for Total Assigned
Beneficiaries was 11,688.50. The median for Generated Total Savings/Losses was 0.00.
The findings show the analyst and interested parties that middle-of-the-road 2018 MSSP
ACO participating providers were mostly high quality with no shared savings, managing
nearly 12,000 beneficiaries. The relevance lies in the fact that one could note
overarchingly that between the highest and the lowest, the middle-performing 2018
MSSP ACO participating providers rendered high quality care for thousands of
beneficiaries, but not with cost savings.
The mode for Quality Score was 1.0000. The mode for Total Assigned
Beneficiaries was 5,230. The Mode for Generated Total Savings/Losses was 0. These
statistics note that most participating 2018 MSSP ACOs had a Quality Score of 1,
managed a Total Assigned Beneficiary pool of just over 5,000 and did not have any
Generated Total Savings or Losses.
The standard deviation of Quality Score was 0.0688419. The standard deviation
of Total Assigned Beneficiaries was 18,572.682. The standard deviation of Generated
Total Savings/Losses ($) was 9,676,813.542. Standard deviation shows how dispersed the
data is related to the mean (average). The lower the standard deviation, data is more
clustered around the mean. The higher the standard deviation, data is more spread out. A
Quality Score standard deviation at nearly 0.07 has data close to the mean. A Total
Assigned Beneficiaries standard deviation over 18,000 means data is not close to the
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mean. A Generated Total Savings/Losses standard deviation of almost 10 million means
data is not at all close to the mean. Therefore, most ACOs have similar Quality Score, but
Total Assigned Beneficiaries and Generated Total Savings/Losses are scattered.
The skewness of Quality Score was -2.037. The skewness of Total Assigned
Beneficiaries was 3.079. The skewness of Generated Total Savings/Losses was 3.666.
Skewness measures the variable deviation of normal distribution from probability
distribution. Skewness can be used to describe the degree of asymmetry. In this study, the
variables with a positive skew greater than zero were Total Assigned Beneficiaries and
Generated Total Savings/Losses; the mean is greater than the medium.
The standard error of skewness for Quality Score was 0.104. The standard error of
skewness for Total Assigned Beneficiaries was 0.104. The standard error of skewness for
Generated Total Savings/Losses was 0.104. Standard error of skewness can be used to
test normality. In this study, normality can be accepted because the findings are between 2 and +2; meaning, the descriptive statistics are within reason.
The kurtosis of Quality Score was 9.083. The kurtosis of Total Assigned
Beneficiaries was 12.068. The kurtosis of Generated Total Savings/Losses was 34.690.
Kurtosis measures the extent of outliers and can be used to describe a distribution. Higher
kurtosis indicates less likelihood of deviations. Normal distributions have a kurtosis value
of zero. Positive kurtosis indicates more outliers. Negative kurtosis indicates less outliers.
The findings of this study note there are some outliers, but seemingly not too extreme.
Data sets with higher kurtosis oftentimes have outliers whereas data sets with
lower Kurtosis tend to lack outliers. In this study, the Quality Score and Total Assigned
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Beneficiaries variables were lower than the Generated Total Savings/Losses variable;
meaning, the two former mentioned variables had less outlier likelihood.
The standard error of kurtosis for Quality Score was 0.208. The standard error of
kurtosis for Total Assigned Beneficiaries was 0.208. The standard error of kurtosis for
Generated Total Savings/Losses was 0.208. Standard error of kurtosis can be used to test
normality. In this study, normality can be accepted because the findings are between -2
and +2; meaning, the descriptive statistics are within reason.
The minimum for Quality Score was 0.4545. The minimum for Total Assigned
Beneficiaries was 605. The minimum for Generated Total Savings/Losses was 45,126,888 (losses of estimated $45 million). These statistics note that the minimum
Quality Score for participating 2018 MSSP ACOs was less than 0.46, the least number of
Total Assigned Beneficiaries managed was 605 and the least Generated Total Savings
was negative; the most Generated Total Losses was $45 million.
The maximum for Quality Score was 1.0. The maximum for Total Assigned
Beneficiaries was 137,516. The maximum for Generated Total Savings/Losses ($) was
112,523,299. These statistics note that the maximum Quality Score for participating 2018
MSSP ACOs was 1, the highest number of Total Assigned Beneficiaries managed was
137,516 and the most Generated Total Savings was nearly $13 million.
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Table 4
Variable Statistics
Total Assigned

Generated Total

Quality Score

Beneficiaries

Savings/Losses

548

548

548

0

0

0

Mean

.929064

18424.95

2850592.38

Median

.937650

11688.50

.00

Mode

1.0000

5230a

0

.0688419

18572.682

9676813.542

-2.037

3.079

3.666

Std. Error of Skewness

.104

.104

.104

Kurtosis

9.083

12.068

34.690

Std. Error of Kurtosis

.208

.208

.208

Minimum

.4545

605

-45126888

Maximum

1.0000

137516

112523299

N

Valid
Missing

Std. Deviation
Skewness
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Figure 1
Quality Score Statistics

This chart shows the mean Quality Score as 0.9291. Most of the participating
MSSP ACOs in the 2018 performance year had a Quality Score of 1. The minimum score
was 0.4545. The maximum score was 1.
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Figure 2
Total Assigned Beneficiaries Statistics

This chart shows the mean Total Assigned Beneficiaries at 18,435. Most of the
participating MSSP ACOs in the 2018 performance year managed 5,230 Total Assigned
Beneficiaries. The minimum number of beneficiaries was 605 and the maximum was
137,516.
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Figure 3
Generated Total Savings/Losses Statistics

This chart shows the mean Generated Total Savings/Losses at $2,850,592. Most
of the participating MSSP ACOs in the 2018 performance year saved CMS $0. The
minimum savings was -$45,126,888; these were losses. The maximum savings was
$112,523,299.
After descriptive statistics were reviewed for the two variables included in RQ1
and the two variables included in RQ2, the researcher/analyst used SPSS to run a simple
linear regression analysis (SPSS: Analyze à Regression à Linear) for the research
questions with the accompanying statistics options chosen in SPSS: Estimates,
Confidence Intervals at 95%, Model Fit, R Squared change, and Descriptive Statistics.
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Additionally, the plots option was chosen in SPSS to include histogram and normal
probability plot.
RQ1: Is there a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants?
H01: There is no statistically significant relationship between the Quality Score
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
H11: There is a statistically significant relationship between the Quality Score and
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
After analyzing the dataset, the null hypothesis was accepted and shown to be the
true hypothesis. The analysis yielded results showing no statistically significant
relationship between Quality Score and Generated Total Savings/Losses for 2018
Medicare Shared Savings Program Accountable Care Organization provider participants.
The data depicted a very low likelihood that their Quality Score impacted Generated
Total Savings (or) Losses in 2018 MSSP ACOs. Meaning, if Quality Score changed (up
or down), Generated Total Savings/Losses did not vary tremendously. In summary,
Quality Score was not a predictor of Generated Total Savings/Losses in the 2018
performance year.
The variables for RQ1 were Quality Score and General Total Savings/Losses;
both scale variables. Quality Score was the independent predictor (constant) variable
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shown on the horizontal X-axis. General Total Savings/Losses was the dependent
variable displayed on the vertical Y-axis. Dependent and independent variables were
updated for SPSS analysis, as described herein.
The variable statistics ran show that the mean Quality Score was 0.93 and the
mean of Generated Total Savings/Losses was $2,850,592. The average participating
MSSP ACO in the 2018 performance year had a Quality Score of 0.93 and saved CMS
$2,850,592. The dataset used a sample size of 548 MSSP ACO participants.
The Pearson correlation results for Quality Score and Generated Total
Savings/Losses were 1.000 and -0.036. This depicts an estimated 3.5% correlation
between Generated Total Savings/Losses being dependent on Quality Score. The data
shows that there is a very low likelihood that Generated Total Savings or Losses in 2018
MSSP ACOs were impacted by their Quality Score.
The significance (one-tailed) for Quality Score and Generated Total
Savings/Losses was 0.199. The difference between the observations is not statistically
significant because it is more than 0.05. Therefore, the null hypothesis is accepted. The
results for RQ1 (is there a statistically significant relationship between the Quality Score
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program
Accountable Care Organization participants?) were that there was not a statistically
significant relationship between Quality Score and Generated Total Savings/Losses for
2018 Medicare Shared Savings Program Accountable Care Organization participants.
The null hypothesis (there is no statistically significant relationship between the Quality
Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program

68
Accountable Care Organization participants) was accepted. The alternative hypothesis
(there is a statistically significant relationship between the Quality Score and Generated
Total Savings/Losses for 2018 Medicare Shared Savings Program Accountable Care
Organization participants) was rejected.
The model summaries included R of 0.036, R square of 0.001, adjusted R square
of -0.001 (nearly 100% of the model is not explained), standard error of the estimate at
9,679,330.245, R square change of 0.001, F change at 0.716, df1 at 1 and df2 at 546 with
change statistics of significant F change at 0.398. The 0.001 R square at 1/10 (1%)
explains the variation as very low. If the Quality Score changes (up or down), Generated
Total Savings/Losses does not vary tremendously; thus, the statistical significance is low.
In summary, the dataset shows that Quality Score is not a predictor of Generated Total
Savings/Losses.
ANOVA analysis showed regression sum of square as 67,043,058,040,096.000.
Regression sum of square depicts how well a regression model represents the data being
modeled. One as high as this means the regression model does not fit the data well.
ANOVA analysis showed residual sum of square as 51,154,430,963,240,432.000 with a
total of 51,221,474,021,280,528.000. Residual sum of square measures modeling error
variation. One as high as this means the regression model poorly explains the data. The
regression mean square was 67,043,058,040,096.000; meaning this regression is not
statistically significant. The residual mean square was 93,689,433,998,608.840; meaning
the residual is not statistically significant. The F was 0.716 and the significance was
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0.398. This is the indicator of probability that the null hypothesis is true. Significance in
the SPSS output is the label for the p-value.
When reviewing unstandardized coefficients in the regression analysis, the
constant beta (B), the intercept of the model, was 7,575,313.704 and the Quality Score B
was -5,085,463.502. Unstandardized beta (B) represents the line slope between the
predictor and dependent variables. The constant standard error was 5,600,559.631 and the
Quality Score standard error was 6,011,722.724. When reviewing unstandardized
coefficients, there was no constant beta. The Quality Score beta was -0.036. The constant
t was 1.353 and the Quality Score t was -0.846. The constant significance was 0.177. The
Quality Score significance was 0.398. At a 95.0% confidence interval for B, the constant
lower bound was -3,425,967.996, the constant upper bound was 18,576,595.405, the
Quality Score lower bound was -16,894,400.386 and the Quality Score upper bound was
6,723,473.382. There is not a statistical significance. These statistics show the strength of
the effect of the independent to the dependent variable. In summary, Quality Score does
not have a strong impact on other variables.
Statistical assumptions were evaluated as appropriate to this study. The residual
statistics, difference between observed and mean value, show a predicted value minimum
of 2,489,850.25, a residual minimum of -48,233,604.000, a standard predicted value
minimum of -1.030 and a standard residual minimum of -4.983 as well as a predicted
value maximum of 5,263,970.50, a residual maximum of 109,567,624.000, a standard
predicted value maximum of 6.894 and a standard residual maximum of 11.320. The
predicted value mean was 2,850,592.38. The residual mean was 0.000. The standard
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predicted value mean was 0.000. The standard residual mean was 0.000. The predicted
value standard deviation was 350,092.853. The residual standard deviation was
9,670,478.547. The standard predicted value standard deviation was 1.000. The standard
residual standard deviation was 0.999. The N (population) was 548 for predicted value,
residual, standard predicted value, and standard residual. The predictions and residuals
note no statistical significance. These findings indicate the extent of the model’s account
of observed data variation. Ultimately, the predictions varied from the observations.
The data analysis indicates that Quality Score is not a statistically significant
predictor of Generated Total Savings/Losses in the 2018 performance year; meaning,
regardless of a 2018 participating MSSP ACO’s Quality Score, there is not a significant
impact on their Generated Total Savings or Losses. The statistical analysis findings of the
unstandardized B are not statistically significant. For every increase in Quality Score,
Generated Total Savings/Losses decreased by $5.6 million. The confidence interval
includes the value of 0; this is not a statistically significant result. The Quality Score
significance is 0.398. In statistical analysis, if the p-value is less than 0.05, it is
statistically significant. As 0.398 is greater than 0.05, the p-value is not statistically
significant. The data relays that there is no statistically significant argument that there is a
relationship between Quality Score and Generated Total Savings/Losses; there is no
correlation between the two variables.
Review of the data visualizations for RQ1 via Histogram, Normal P-P Plot of
Regression Standardized Residual and Scatterplot were appropriate and characterized the
sample. This study did not require post-hoc analyses or related reported results. There

71
was no need to report any additional statistical tests of hypotheses that emerged from the
analysis of main hypotheses for the study. All pertinent tables and figures to illustrate
results were included herein.
Regression
Table 5
Variable Statistics
Mean

Std. Deviation

N

Generated Total Savings/Losses

2850592.38

9676813.542

548

Quality Score

.929064

.0688419

548

Table 6
Correlations
Generated Total
Pearson Correlation

Savings/Losses

Quality Score

1.000

-.036

Quality Score

-.036

1.000

Generated Total

.

.199

Quality Score

.199

.

Generated Total

548

548

Generated Total
Savings/Losses

Sig. (1-tailed)

Savings/Losses

N

Savings/Losses
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Table 7
Variables Entered/Removed
Model

Variables Entered

Variables Removed

Method

1

Quality Scoreb

.

Enter

a. Dependent Variable: Generated Total Savings/Losses
b. All requested variables entered.
Table 8
Model Summary
Change Statistics
Adjusted Std. Error of R Square
Model
1

R

R Square R Square the Estimate

.036a

.001

-.001

9679330.245

F

Change

Change

df1

df2

.001

.716

1

546

Change Statistics
Model

Sig. F Change

1

.398

a. Predictors: (Constant), Quality Score
b. Dependent Variable: Generated Total Savings/Losses
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Table 9
ANOVA
Model
1 Regression

Sum of Squares

df

Mean Square

F

Sig.

67043058040096.000

1

67043058040096.000

.716

.398b

Residual 51154430963240432.000 546 93689433998608.840

Total

51221474021280528.000 547

a. Dependent Variable: Generated Total Savings/Losses
b. Predictors: (Constant), Quality Score
Table 10
Coefficients
Unstandardized

Standardized

95.0% Confidence Interval for

Coefficients

Coefficients

B

Coefficients
Model
1

B

Std. Error

(Constant) 7575313.704 5600559.631
Quality

Beta

t

Sig.

Lower

Upper

Bound

Bound

1.353 .177 -3425967.996 18576595.405

-5085463.502 6011722.724 -.036 -.846 .398 -16894400.386 6723473.382

Score
a. Dependent Variable: Generated Total Savings/Losses
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Table 11
Residuals Statistics
Std.

Predicted Value
Residual
Std. Predicted

Minimum

Maximum

2489850.25

5263970.50

Mean

Deviation

2850592.38 350092.853

-48233604.000 109567624.000

N
548

.000

9670478.547

548

-1.030

6.894

.000

1.000

548

-4.983

11.320

.000

.999

548

Value
Std. Residual

a. Dependent Variable: Generated Total Savings/Losses
Figure 4
Histogram – DV: Generated Total Savings/Losses
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The DV Generated Total Savings/Losses Histogram depicts the frequency and
regression standardized residual of 2018 performance year MSSP ACOs: whether they
saved or lost millions of U.S. dollars. The x-axis shows the losses or savings. The y-axis
shows the number of 2018 performance year MSSP ACOs. This chart shows how often
Generated Total Savings/Losses occurs. Visually, 0 was the most frequent occurrence.
Meaning, most of the 2018 MSSP ACOs had $0 in Generated Total Savings/Losses.
Figure 5
Normal P-Plot – DV: Generated Total Savings/Losses

The DV Generated Total Savings/Losses Normal P-Plot of Regression
Standardized Residual depicts probability of 2018 performance year MSSP ACOs. The xaxis shows the observed cumulative probability. The y-axis shows the expected
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cumulative probability. This chart shows the observation of Generated Total
Savings/Losses occurrence and the expectation of Generated Total Savings/Losses
occurrence was not aligned.
Figure 6
Scatterplot – DV: Generated Total Savings/Losses

The DV Generated Total Savings/Losses Scatterplot depicts predicted and
residual standardized regression. The x-axis shows regression standardized predicted
value. The y-axis shows the regression standardized residual of 2018 performance year
MSSP ACOs. This chart shows that most participating MSSP ACOs in the 2018
performance year had around $0 of Generated Total Savings/Losses. There were outliers,
but not enough to totally skew the clear visualization that most 2018 MSSP ACOs are
scattered around the $0 savings mark.
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After reviewing RQ1, the researcher/analyst used SPSS to run a simple linear
regression analysis (SPSS: Analyze à Regression à Linear) for RQ2 with the same
accompanying Statistics options chosen in SPSS for the RQ1 analysis: Estimates,
Confidence Intervals at 95%, Model Fit, R Squared change, and Descriptives.
Additionally, the Plots option was chosen in SPSS to include histogram and normal
probability plot.
RQ2: Is there a statistically significant relationship between the Quality Score and
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable
Care Organization participants?
H02: There is no statistically significant relationship between the Quality Score
and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program
Accountable Care Organization participants.
H12: There is a statistically significant relationship between the Quality Score and
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable
Care Organization participants.
After analyzing the dataset, the null hypothesis was accepted and showed to be
the true hypothesis. The analysis yielded results showing no statistically significant
relationship between Quality Score and Total Assigned Beneficiaries for 2018 Medicare
Shared Savings Program Accountable Care Organization provider participants. The data
depicted a very low likelihood that Quality Score in 2018 MSSP ACOs was impacted by
Total Assigned Beneficiaries. Meaning, if Total Assigned Beneficiaries changed (up or
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down), Quality Score did not vary tremendously. In summary, Total Assigned
Beneficiaries was not a predictor of Quality Score
The variables for RQ2 were Quality Score and Total Assigned Beneficiaries, both
scale variables. As such, Quality Score was the dependent variable shown on the vertical
Y-axis and Total Assigned Beneficiaries was the independent predictor (constant)
variable displayed on the horizontal X-axis. Dependent and independent variables were
updated for SPSS analysis, as described herein.
The variable statistics ran show that the mean Quality Score was 0.93 and the
mean of Total Assigned Beneficiaries was 18,425. The average participating MSSP ACO
in the 2018 performance year had a Quality Score of .93 and managed 18,425 members.
The Pearson correlation results for Quality Score and Total Assigned
Beneficiaries were 1.000 and 0.007. This depicts an estimated 0.7% correlation between
Quality Score and Total Assigned Beneficiaries. The data showed that there is a very low
likelihood that Quality Score in 2018 MSSP ACOs was impacted by Total Assigned
Beneficiaries.
The significance (one-tailed) for Quality Score and Total Assigned Beneficiaries
was 0.432. The difference between the observations is not statistically significant and the
null hypothesis is accepted. The results for RQ2 (is there a statistically significant
relationship between the Quality Score and Total Assigned Beneficiaries for 2018
Medicare Shared Savings Program Accountable Care Organization participants?) were
that there was not a statistically significant relationship between Quality Score and Total
Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable Care
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Organization participants. The null hypothesis (there is no statistically significant
relationship between the Quality Score and Total Assigned Beneficiaries for 2018
Medicare Shared Savings Program Accountable Care Organization participants) was
accepted. The alternative hypothesis (there is a statistically significant relationship
between the Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared
Savings Program Accountable Care Organization participants) was rejected.
The model summaries included R of 0.007, R square of 0.000, adjusted R square
of -0.002, standard error of the estimate at 0.0689031, R square change of 0.000, F
change at 0.029, df1 at 1 and df2 at 546 with change statistics of significant F change at
0.865. The 0.000 R square at 0/0 (0%) explains the variation is nothing. Meaning, if Total
Assigned Beneficiaries changes (up or down), Quality Score does not vary at all; thus,
there is no statistical significance. In summary, the dataset shows Total Assigned
Beneficiaries is not a predictor of Quality Score.
ANOVA analysis showed the regression sum of squares as 0.000. Regression sum
of square depicts how well a regression model represents the data being modeled. A low
sum of squares means the regression model fits the data well. ANOVA analysis showed
residual sum of squares as 2.592 with a total of 2.592. Residual sum of square measures
modeling error variation. The regression mean square was 0.000; meaning, the model is
perfect. The residual mean square was 0.005. The regression F was 0.029 and the
regression significance was 0.865. This is the indicator of probability that the null
hypothesis is true. Significance in the SPSS output is the label for the p-value.
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When reviewing unstandardized coefficients in the regression analysis, the
constant B was 0.929 and the Total Assigned Beneficiaries B was 2.698E-8, while the
constant standard error was 0.004 and the Total Assigned Beneficiaries standard error
was 0.000. When reviewing standardized coefficients, there was no constant beta. The
Total Assigned Beneficiaries beta was 0.007. The constant t was 223.862 and the Total
Assigned Beneficiaries t was 0.170. The constant significance was 0.000. The Total
Assigned Beneficiaries significance was 0.865. At a 95% confidence interval for B, the
constant lower bound was 0.920. The constant upper bound was 0.937. The Total
Assigned Beneficiaries lower bound was 0.000 and the Total Assigned Beneficiaries
upper bound was 0.000. Meaning, there is not a statistical significance. These statistics
show the strength of the effect of the independent to the dependent variable. In summary,
Total Assigned Beneficiaries does not have a strong impact on other variables.
Statistical assumptions were evaluated as appropriate to this study. The residual
statistics showed a predicted value minimum of 0.928583, a residual minimum of 0.4750648, a standard predicted value minimum of -0.959 and a standard residual
minimum of -6.895 as well as a predicted value maximum of 0.932278, a residual
maximum of 0.0713072, a standard predicted value maximum of 6.412 and a standard
residual maximum of 1.035. The predicted value mean was 0.929064. The residual mean
was 0.0000000. The standard predicted value mean was 0.000. The standard residual
mean was 0.000. The predicted value standard deviation was 0.0005012. The residual
standard deviation was 0.0688401. The standard predicted value standard deviation was
1.000. The standard residual standard deviation was 0.999. The population was 548 for
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predicted value, residual, standard predicted value, and standard residual. The predictions
and residuals note no statistical significance.
The dataset shows that Total Assigned Beneficiaries is not a predictor of Quality
Score. The statistical analysis findings of the unstandardized B are not statistically
significant because for every increase in Total Assigned Beneficiaries, Quality Score
decreased by 0.004 (0.4%). The confidence interval includes the value of 0; this is not a
statistically significant result. The Total Assigned Beneficiaries significance is 0.865. In
statistical analysis, if the p-value is less than 0.05, it is statistically significant. As 0.865 is
greater than the p-value, it is not statistically significant. The data relays that there is no
statistically significant argument that there is a relationship between Total Assigned
Beneficiaries and Quality Score; there is no association between the two variables.
Review of the data visualizations for RQ 2 via histogram, normal p-plot of
regression standardized residual and scatterplot were appropriate and characterized the
sample. There was not a need in this study for post-hoc analyses of statistical tests. Thus,
there were no reported results of such. Additionally, there was no need to report any
further statistical tests of hypotheses that emerged from the main hypotheses. All
pertinent tables and figures to illustrate results were included herein.
Regression
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Table 12
Variable Statistics
Mean

Std. Deviation

N

Quality Score

.929064

.0688419

548

Total Assigned Beneficiaries

18424.95

18572.682

548

Table 13
Correlations
Total Assigned
Quality Score

Beneficiaries

Quality Score

1.000

.007

Total Assigned Beneficiaries

.007

1.000

Quality Score

.

.432

Total Assigned Beneficiaries

.432

.

Quality Score

548

548

Total Assigned Beneficiaries

548

548

Pearson Correlation
Sig. (1-tailed)
N

Table 14
Variables Entered/Removed
Model

Variables Entered

Variables Removed

Method

1

Total Assigned

.

Enter

Beneficiariesb
a. Dependent Variable: Quality Score
b. All requested variables entered.
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Table 15
Model Summary
Std. Error

Change Statistics

R

Adjusted R

of the

R Square

F

Model

R

Square

Square

Estimate

Change

Change

df1

df2

1

.007a

.000

-.002

.0689031

.000

.029

1

546

Change Statistics
Model

Sig. F Change

1

.865

a. Predictors: (Constant), Total Assigned Beneficiaries
b. Dependent Variable: Quality Score
Table 16
ANOVA
Model
1

Sum of Squares

df

Mean Square

F

Sig.

Regression

.000

1

.000

.029

.865b

Residual

2.592

546

.005

Total

2.592

547

a. Dependent Variable: Quality Score
b. Predictors: (Constant), Total Assigned Beneficiaries
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Table 17
Coefficients
95.0%
Confidence
Unstandardized

Standardized

Interval for

Coefficients

Coefficients

B
Lower

Model

B

Std. Error

(Constant)

.929

.004

Total Assigned

2.698E-8

.000

1

Beta

t

Sig.

223.862 .000
.007

.170

.865

Bound
.920
.000

Beneficiaries
95.0% Confidence Interval
for B
Model
1

Upper Bound

(Constant)

.937

Total Assigned Beneficiaries

.000

Table 18
Residuals Statistics
Minimum

Maximum

Mean

Std. Deviation

N

Predicted Value

.928583

.932278

.929064

.0005012

548

Residual

-.4750648

.0713072

.0000000

.0688401

548

Std. Predicted Value

-.959

6.412

.000

1.000

548

Std. Residual

-6.895

1.035

.000

.999

548

a. Dependent Variable: Quality Score
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Charts
Figure 7
Histogram – DV: Quality Score

The DV Quality Score histogram depicts the frequency of regression standardized
residual. The x-axis shows the regression standardized residual. The y-axis shows
frequency of 2018 performance year MSSP ACOs. This chart shows how often (how
many participating MSSP ACOs in the 2018 performance year) had a certain Quality
Score. Visually, a score of 1 (between 0 and 2) was the most frequent occurrence.
Meaning, most of the 2018 MSSP ACOs had a Quality Score of 1.
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Figure 8
Normal P-Plot – DV: Quality Score

The DV Quality Score normal p-plot of regression standardized residual depicts
probability of 2018 performance year MSSP ACOs. The x-axis shows the observed
cumulative probability. The y-axis shows the expected cumulative probability. This chart
shows the expectations of probability of Quality Score occurrence and the expected
probability of Quality Score occurrence was close from 0 through 0.8 then the observed
probability tapered off.
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Figure 9
Scatterplot – DV: Quality Score

The DV Quality Score scatterplot depicts predicted and residual standardized
regression. The x-axis shows regression standardized predicted value. The y-axis shows
the regression standardized residual of 2018 performance year MSSP ACOs. This chart
shows that most participating MSSP ACOs in the 2018 performance year had a Quality
Score of 1. There were outliers, but not enough to totally skew the clear visualization that
most Quality Scores are scattered around 1.
Summary
After the secondary dataset was quantitatively analyzed, I was able to review the
study’s two research questions, understand the statistically significant relationships
between Quality Score and Generated Total Savings/Losses as well as Quality Score as
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Total Assigned Beneficiaries for MSSP ACO participants in the 2018 performance year
and note if each of the null and alternative hypotheses were respectively accepted or
rejected.
The results for RQ1 (is there a statistically significant relationship between the
Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings
Program Accountable Care Organization participants?) were that there was not a
statistically significant relationship between Quality Score and Generated Total
Savings/Losses for 2018 Medicare Shared Savings Program Accountable Care
Organization participants. The null hypothesis (there is no statistically significant
relationship between the Quality Score and Generated Total Savings/Losses for 2018
Medicare Shared Savings Program Accountable Care Organization participants) was
accepted. The alternative hypothesis (there is a statistically significant relationship
between the Quality Score and Generated Total Savings/Losses for 2018 Medicare
Shared Savings Program Accountable Care Organization participants) was rejected.
The findings for RQ1 were that there was no statistically significant relationship
between Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared
Savings Program Accountable Care Organization provider participants. The data showed
a very low likelihood that their Quality Score impacted Generated Total Savings (or)
Losses in 2018 MSSP ACOs. Meaning, if Quality Score changed (up or down),
Generated Total Savings/Losses did not vary tremendously; thus, the statistical
significance was low. The data showed no statistically significant argument that there is a
relationship between Quality Score and Generated Total Savings/Losses; there is no
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correlation between the two variables. In summary, the dataset shows that Quality Score
was not a predictor of Generated Total Savings/Losses.
Any potential notion that 2018 MSSP ACO participants’ Generated Total
Savings/Losses in 2018 MSSP ACOs could be impacted by Quality Score is refuted by
these findings. This study’s findings are important to MSSP ACO policy creation and
program management. MSSP ACOs stakeholders (proponents and opponents alike)
would likely want to review findings that show a lack of statistical significance between
Quality Score and Generated Total Savings/Losses for 2018 MSSP ACOs. This is critical
to note because of the idea that one cannot assume that a certain Quality Score predicts
the potential for savings or losses.
The results for RQ2 (is there a statistically significant relationship between the
Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings
Program Accountable Care Organization participants?) were that there was not a
statistically significant relationship between Quality Score and Total Assigned
Beneficiaries for 2018 Medicare Shared Savings Program Accountable Care
Organization participants. The null hypothesis (there is no statistically significant
relationship between the Quality Score and Total Assigned Beneficiaries for 2018
Medicare Shared Savings Program Accountable Care Organization participants) was
accepted. The alternative hypothesis (there is a statistically significant relationship
between the Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared
Savings Program Accountable Care Organization participants) was rejected.

90
The findings for RQ2 were that there was no statistically significant relationship
between Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared
Savings Program Accountable Care Organization provider participants. The data showed
that there is a very low likelihood that Total Assigned Beneficiaries impacted Quality
Score in 2018 MSSP ACOs. Meaning, if Total Assigned Beneficiaries changed (up or
down), Quality Score did not vary tremendously; thus, the statistical significance was
low. The data showed no statistically significant argument that there is a statistically
significant relationship between Quality Score and Total Assigned Beneficiaries; there is
no correlation between the two variables. In summary, the dataset shows that Total
Assigned Beneficiaries was not a predictor of Quality Score.
Any potential notion that 2018 MSSP ACO participants’ Quality Score in 2018
MSSP ACOs could be impacted by Total Assigned Beneficiaries is refuted by these
findings. The findings are important to MSSP ACO policy creation and program
management. MSSP ACOs stakeholders (proponents and opponents alike) would likely
want to review findings that show a lack of statistical significance between Quality Score
and Total Assigned Beneficiaries for 2018 MSSP ACOs. This is critical to note because
one cannot assume that the total number of assigned beneficiaries predicts a certain
Quality Score.
Important to recall are some notes from the literature review: the overarching goal
of the MSSP should not be how many ACOs participate, but how successful those that do
participate are in improving patient care (Meltzer, 2018) and sound management of
quality could yield better beneficiary health care patterns (Beaton, 2018).
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Section 4 will review the purpose of the doctoral research study, the reason the
study was conducted, the key findings and interpretations of such, limitations of the
study, recommendations for future research, and applications to professional practice and
implications for social change.
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Section 4: Application to Professional Practice and Implications for Social Change
The purpose of this study was to review and understand the relationship between
generated total savings/losses, Quality Score, and total assigned beneficiaries for 2018
MSSP ACO participants. For this quantitative study, I used secondary data to address two
research questions. This study needed to be conducted on a micro level to note the 2018
performance year relationship of quality and cost indicators for the managed population
of the MSSP. On a macro level, this study needed to be conducted to understand the
impact MSSPs have on the overarching U.S. health care goals to increase quality and
decrease costs for managed populations in the Medicare space, moving more towards
value-based care.
Even though the data analysis results showed no statistically significant
relationship between Quality Score and Generated Total Savings/Losses nor between
Quality Score and Total Assigned Beneficiaries for 2018 MSSP ACO provider
participants, this study contributed to positive social change by creating a new vantage
point for review of their quality, costs, and assigned beneficiaries. The development and
understanding of ACO initiatives are essential pieces required for meeting federal valuebased care and alternative payment model U.S. health care goals. From a quality
perspective, this is critical for Medicare beneficiaries and from a cost perspective, this is
important for U.S. taxpayers. Other methods one could use to better understand the
relationship between quality and cost may be to review cost of services rendered by
different provider types (e.g., specialist, primary care provider, or other advanced
practicing provider) or diagnosis across various service points (e.g., inpatient or
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outpatient FQHCs, RHCs, SNFs, surgical centers, rehabilitation centers, etc.).
Additionally, reviewing geography, ethnicity, gender, and/or age groups would likely
yield different results than those found in this study.
The data statistics consisted of public data from the CMS, a federal resource, for
the MSSP ACO 2018 performance year. This allowed me to employ recent data via a
standard analytical file to efficiently summarize information for Medicare beneficiaries
and ACO providers for the 2018 performance year of the MSSP. In this research study, I
noted the relationship amongst Generated Total Savings/Losses, Quality Score, and Total
Assigned Beneficiaries, reviewed the literature, and presented potential further research
on whether MSSP ACOs can be considered as a way to lower costs and increase quality
as it relates to serving the Medicare population. The results of this study showed no
statistical significance between Quality Score and Generated Total Savings/Losses and no
statistical significance between Quality Score and Total Assigned Beneficiaries.
Understanding these results, further research could focus on other MSSP ACO
performance years, addition of further variables (within the constraints of MSSP ACOs
or not) or other variables impacting overall quality and cost.
In RQ1, the predictor/independent variable was Quality Score and the
outcome/dependent variable was Generated Total Savings/Losses. The key findings from
the data analysis were that there was no statistically significant relationship between
Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings
Program Accountable Care Organization provider participants. The null hypothesis was
accepted and the alternative hypothesis was rejected. The results of the simple linear
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regression data analysis indicated there was a very low likelihood (i.e., no statistically
significant relationship) that the Quality Score impacted Generated Total Savings (or)
Losses in 2018 MSSP ACOs, meaning that if Quality Score changed (up or down),
Generated Total Savings/Losses did not vary tremendously. In summary, the dataset
review showed that Quality Score was not a predictor of Generated Total Savings/Losses.
In RQ2, the predictor/independent variable was Total Assigned Beneficiaries and
the outcome/dependent variable was Quality Score. The simple linear regression data
analysis concluded that there was no statistically significant relationship between Quality
Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program
Accountable Care Organization provider participants. The null hypothesis was accepted
and the alternative hypothesis was rejected. The data indicated there was a very low
likelihood (i.e., no statistically significant relationship) that Total Assigned Beneficiaries
impacted Quality Score in 2018 MSSP ACOs. In other words, if Total Assigned
Beneficiaries changed (up or down), Quality Score did not vary tremendously. In
summary, the dataset review noted that Total Assigned Beneficiaries was not a predictor
of Quality Score.
The findings of the research questions are important. While, quantitatively, this
study’s results found that there were no statistically significant findings for either
research question, future analysts of the same dataset could review other variables outside
of those analyzed herein: Quality Score, Generated Total Savings/Losses and Total
Assigned Beneficiaries of 2018 MSSP ACOs to find some levels of statistically
significance related to quality and costs of the assigned beneficiaries. Examples of
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variables that could be studied include, but are not limited to, ACO participation start
date, track, type, SNF waiver participant, benchmark, revenue expense category and per
capita expenses. Additionally, the statistical significance of the relationship amongst
Quality Score, Generated Total Savings/Losses and Quality Score and Total Assigned
Beneficiaries could be studied for other MSSP ACO performance years (e.g., 2012, 2013,
2014, 2015, 2016, 2017, 2019 and beyond). Additionally, reviewing patient satisfaction
surveys specifically related to quality of care could create an avenue of additional
research.
Interpretation of the Findings
The data analysis findings contrasted with the literature review presented in
Section 1 of this study. Whereas the literature pointed to variable (cost, quality, attributed
beneficiaries) connectivity, the data analysis did not yield a statistical significance
between the independent and dependent variables included in the research questions.
In terms of the theoretical framework, the study’s findings align with GST, as
noted earlier in this work. U.S. health care is a system with complex interacting elements,
continually evolving parts, emerging properties, and broad concepts in a dynamic and
active ecosphere with various outcomes. GST is applicable and helps make sense of the
contrasting literature review and data analysis. Since the data analysis showed no
statistical significance between Quality Score, Generated Total Savings/Losses, and Total
Assigned Beneficiaries, there could be randomness occurring with MSSP ACOs
increasing quality and decreasing cost overall. The fact that various layers exist in the
system that relates their intersecting trends and patterns helps a reviewer understand
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behaviors of interrelatedness and interdependence can differ quantitatively versus
qualitatively.
The scope of the study allowed for analysis and interpretation of the data. The
findings showed no statistically significant relationship between Quality Score and
Generated Total Savings/Losses, and there was no statistically significant relationship
between total Assigned Beneficiaries for 2018 MSSP ACOs.
Limitations of the Study
This work's limitations included data, analysis, and trending reports provided by
the federal government and engaged, interested, likely proponents, and/or participating
organizations of MSSPs for the years of implementation, participation, and reporting.
Therefore, the findings in terms of quality, cost and beneficiaries (Quality Score does not
have a statistically significant relationship with Total Generated Savings/Losses and
Quality Score does not have a statistically significant relationship with Total Assigned
Beneficiaries) cannot be representative of the entire health care system nor even all of the
Medicare-eligible population (as a large percentage of beneficiaries participate in a
Medicare Advantage plan or none, at all) and does not compare MSSP ACOs to non
MSSPs ACO that may also be generating a higher value for the same variables of this
study. While the Medicare FFS program may show that certain MSSP ACOs have
generated savings for that specific sector of the population, it does not negate that the
entire system’s cost could still be rising, and quality could still be declining.
The challenges that arise when one attempts to review a relatively new program in
a dynamic environment in an evolving, ever-changing system are that things do not
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remain static. It is difficult to ensure sound statistical analysis when there are frequent
changes, year-over-year, to the quality measures or the cost-savings factors. Systematic
and technical adjustments, as well as realignment, must be made by providers that may
cause indifferent results. It is difficult to measure certain quality metrics when there are
so many outlying issues affecting the result. One must review data and reasoning but
understand there are retrospective changes that occur and arguments to the methodology
that make sense in the space that must be considered. Other initiatives, alternative and
bundled payment methodologies, changes in Medicare rules, inpatient and outpatient
treatment differentials, skilled nursing and rehabilitation components, and various other
advents of evidence-based practices geared toward ensuring proper care across all
provider types can have a compounding, comprehensive effect on MSSP ACOs quality,
costs, and attributed beneficiaries. These extraneous variables change constantly
throughout a MSSP ACO’s performance year and have an impact on cost and quality.
The data analysis allowed for further audit of generalizability limitations. One
cannot consider the general notion that all Medicare beneficiary pools would yield this
study’s same results in terms of cost and quality relationships. Relatedly, there cannot be
a generalization made that all MSSP ACO provider participants in various performance
years would render services that result in similar findings. It can be generalized that
Medicare beneficiaries are not all treated equitably in terms of accountable care service
renderings and outcomes-based measurement amongst different providers across various
programs in disparate geographies.
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The trustworthiness of the findings was as deep and broad as the CMS data
sharing would allow. The CMS’ MSSP ACO program follows data integrity and
transparency principles appropriate for federal source data. As noted earlier in this work,
the data's validity via the published dataset on the CMS government website has been
argued as unable to predict counterfactual scenarios. Specifically, it is hard to know what
would have been spent on CMS covered benefits for the population served if ACOs did
not exist (LaPointe, 2017). This instrument was previously used in performance years
2012, 2013, 2014, 2016, and 2017 with the same Medicare population but with slightly
different measures and modes of interpretation.
The data's validity does not consider other potential interaction effects and
reactiveness of arrangements or program participation maturity, experimental mortality,
equitable risk ownership, and selection interaction.
Also noted earlier in this study, the reliability concerns that arose with the
secondary data set included the difficulty, or near impossibility, of extracting the effects
that other Medicare changes, regulations and programs have on the MSSP. For example,
and as previously noted in this study, changes in Medicare rules regarding inpatient days,
bundled payments for services, and other advents geared toward ensuring proper care
across all provider types can and will very likely have a compounding, comprehensive
effect on other initiatives being studied, such as MSSP ACOs. This is beyond the scope
of this work but is a means for future study.
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Recommendations
This study reviewed Quality Score, Generated Total Savings/Losses, and Total
Assigned Beneficiaries of MSSP ACOs in the 2018 performance year. Recommendations
for further research include expanding the review to analyze other MSSP ACO variables
such as expenses per capita, place of service, admission rates, number of managed
beneficiaries, Hierarchical Condition Category (HCC) risk scores of certain conditions;
related to geography, age range, race and/or gender or assessing other performance years’
MSSP ACO dataset. By expanding the review, analyzing additional variables and/or
assessing different performance years, it could benefit interested parties to provide
expanded context on overall MSSP ACO success
Another option for future research could be to analyze the same independent and
independent variables of this study, but for other MSSP ACO performance years to
confirm, refute and/or compare this study’s findings. In addition to the opportunity to
review performance years 2012-2017, reviewing 2019 MSSP ACO data (and 2020 when
it becomes publicly available in late 2021) would be appropriate to understand year-overyear matured variation in the three variables reviewed in this study. These
recommendations are grounded in the strengths and limitations of the current study and
literature reviewed in Section 1 and did not exceed the study boundaries.
As Falk (2016) noted, there have been studies that showed statistically significant
correlations of data elements related to MSSP ACO generated savings, but none to date,
that analyze the relationship between costs and quality as it relates to total assigned
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beneficiaries. This study helps fill the gap that Falk (2016) examined (on 2014 MSSP
data) that was present at the time of writing.
Implications for Professional Practice and Social Change
Professional Practice
A competitive strategic approach for health care administrators leading various
health care organizations is in many ways dependent on properly understanding the
relationship of quality and cost measures to the population under organizational
management (Arsita & Idris, 2019). For example, quality improvements could lead to an
increase in generated total savings.
This study offers health care administrative and clinical professionals’ practical
evidence and understanding of the relationship between Quality Score, Generated Total
Savings/Losses, and Total Assigned Beneficiaries among 2018 MSSP ACOs and what
could continue to be examined in the future as it relates to the MSSP. The extraneous
variables noted in this study could be addressed and opportunities and/or suggestions for
control could be provided. The literature review helped support the professional practice
of health care, in general. It demonstrated practical application by presenting that MSSP
ACOs may be an avenue for reaching the overarching U.S. health care system goals of
achieving better care for individuals and better health for populations while lowering the
growth in expenditures (National Association of ACOs, 2018).
The results of this study yield no statistically significant relationship between
Quality Score and Generated Total Savings/Losses nor between Quality Score and Total
Assigned Beneficiaries for 2018 MSSP ACO provider participants. The outcomes of this
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research allow for further understanding of the statistical significance between cost,
quality, and beneficiaries. This examination of 2018 MSSP ACOs renders useful findings
that can either confirm or refute MSSP ACO stakeholder thoughts and opinions and
initiate potential next steps relevant to organizational needs. By utilizing this evidence,
interested parties can better understand the statistically significant relationship between
cost, quality, and beneficiary variables in the 2018 MSSP ACO performance year data.
Stakeholders can use this information to argue for or against further advancing MSSP
ACOs. For example, as this study’s findings yield there is no statistically significant
relationship between Quality Score and Total Generated Savings/Losses, one could argue
for 2018 MSSP ACO participants that it does not matter what the Quality Score is, there
is not a predictability factor for Total Generated Savings/Losses as it relates to the MSSP.
Similarly, as this study’s findings yield there is no statistically significant relationship
between Quality Score and Total Assigned Beneficiaries, one could argue that it doesn’t
matter how large the attributed managed population is, there is not a predictability related
to overall Quality Score.
As previously noted in this study, extraneous variables likely played a role in the
results of this analysis. For example, this study did not take into account if the reviewed
2018 MSSP ACO participants engaged in any other CMS healthcare transformation
efforts under accountable care (such as the Comprehensive End-Stage Renal Disease
Care Model, the Medicare Health Care Quality Demonstration and the Vermont AllPayer ACO Model), episode-based payment initiatives (such as Bundled Payments for
Care Improvement Initiative, Comprehensive Care for Joint Replacement Model and
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Oncology Care Model) nor primary care transformation (Comprehensive Primary Care
Plus, Independence at Home Demonstration and Primary Care First Model).
As such, there are serious practical implications and recommendations for
professional practice. For example, NAACOs and other MSSP ACO proponents are
interested in understanding the statistical significance of related elements (cost and
quality included) that lead to the maturation of U.S. value-based health care. PPACA was
predicated and the Center for Medicare and Medicaid Innovation has built further policies
into the assumption and assertion that population health can be managed to increase the
overall quality and decrease cost.
The methodological implications were grounded in a non-experimental research
design using secondary data quantitative analysis of a PUF. This method was used
because the data variables were studied but not manipulated in any way. The researcher
had specific research questions and hypothesized the relationships among the
independent and dependent variables. The methodology of inquiry was a systematic
review and strategic analysis of said publicly available secondary data for MSSP ACO
participants in the 2018 performance year to note the relationship between Quality Score
to Generated Total Savings/Losses and Quality Score to Total Assigned Beneficiaries.
Theoretically, basing this study on GST allowed the researcher to review a
complex system with interrelated and evolving parts. This study examined the 2018
MSSP ACO performance year, noting how participants behaved in the ever-changing
health care environment and specifically reviewed the relationship between three
different variables (Quality Score, Generated Total Savings/Losses, and Total Assigned
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Beneficiaries). The implications of this study’s theoretical foundation allowed for
correlating how value-based care may help improve the U.S. health care system and
understand the statistically significant relationship among the analyzed variables.
Implications from an empirical perspective included the data analysis that yielded
no statistically significant relationship between Quality Score and Generated Total
Savings/Losses, and there was no statistically significant relationship between Quality
Score and Total Assigned Beneficiaries for 2018 MSSP ACO provider participants. This
study’s findings imply that Quality Score was not a predictor of Generated Total
Savings/Losses and Total Assigned Beneficiaries was not a predictor of Quality Score for
2018 MSSP ACO performance year data.
Positive Social Change
Interested parties look to better understand how MSSP ACOs will lead to positive
social change for health care stakeholders of all kinds: patients, providers, public payers,
private constituents, policymakers, researchers, and the like. If MSSP ACOs can decrease
U.S. health care costs while concurrently increasing quality for managed populations,
there is a compelling argument for their staying power in the system. If able to maintain
momentum and prove transformative, MSSP ACOs could forever change the health care
landscape. One of the essential components of understanding how to scale the success of
MSSP ACOs is to relate the variables and understand their impact (or not) on each other.
Success of value-based care and its ability to move the U.S. health care system
toward higher quality and lower costs, will depend on understanding the markers of ACO
success thus far, a continuation of initiatives that have worked well, and a development of
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increased innovation geared towards improved quality and reduced costs (Moloney,
2015). Also, of importance is the need to further strengthen the program for longevity and
viability (Sweeney, 2018).
This study reviewed the literature on MSSP ACOs and analyzed a public use file
data set as it related to Generated Total Savings/Losses, Quality Score, and Total
Assigned Beneficiaries in the 2018 performance year to understand the relationship
between the variables. This study's findings have impacts for positive social change as it
relates to value-based health care in the United States. Specifically, this study resulted in
no statistically significant relationships between Quality Score and Generated Total
Savings/Losses nor between Quality Score and Total Assigned Beneficiaries for 2018
MSSP ACO participants. The findings provide interested parties insights into how these
specific variables of 2018 MSSP ACOs were correlated and the impact they had on each
other in the performance year. Quality Score was not a statistically significant predictor
of Generated Total Savings/Losses, and Total Assigned Beneficiaries was not a
statistically significant predictor of Quality Score. Stakeholders can use this information
to create further avenues of awareness that certain variables may or may not have
correlations. The implications noted for social change did not exceed the study
boundaries.
This study was conducted on a micro level to note the 2018 performance year
relationship of quality and cost indicators for the managed population of the MSSP. On a
macro level, this study was conducted to understand the relational impact MSSPs have on
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the overarching U.S. health care goals to increase quality and decrease costs for managed
populations in the Medicare space, moving more towards value-based care.
This study's positive social change includes the understanding of the relationship
between quality, cost and total assigned beneficiaries and the related movement toward
value-based care in terms of lowered costs and increased quality for the U.S. health care
system, specifically stemming from 2018 MSSP ACOs. From a quality perspective, this
is critical for Medicare beneficiaries, and from a cost perspective, this is important for
U.S. taxpayers.
Conclusion
In conclusion, this study reviewed the literature on MSSP ACOs and analyzed a
public use file data set as it related to Generated Total Savings/Losses, Quality Score and
Total Assigned Beneficiaries in the 2018 performance year to understand the relationship
between the variables. The purpose of the doctoral research study, the reason the study
was conducted, the key findings and interpretations of such, limitations of the study,
recommendations for future research, and applications to professional practice and
implications for social change, were reviewed herein.
The literature review demonstrated that MSSP ACOs are an avenue to lower costs
and increase quality related to serving Medicare beneficiaries. There were a multitude of
sources that noted MSSP ACOs were a viable option for U.S. health care administrators
to reach systemic goals due to their positive effect on cost and quality. Tu et al. (2015)
posited that MSSP ACOs can help lessen the fragmentation and misalignment and move
the United States towards more value-based health care renderings while improving

106
assigned population health and reducing costs. The National Association of Accountable
Care Organizations (2018) argued that MSSP ACOs can help ensure care quality is
enhanced. The OIG reported that most ACOs had instituted various strategies that have
proven successful in lowering Medicare spending (King, 2019).
This study’s data analysis yielded findings that there was no statistically
significant relationship between Quality Score and Generated Total Savings/Losses and
there was no statistically significant relationship between Quality Score and Total
Assigned Beneficiaries for 2018 MSSP ACO provider participants. Quality Score was not
a predictor of Generated Total Savings/Losses, and Total Assigned Beneficiaries was not
a predictor of Quality Score.
It is an interesting circumstance and potentially controversial that the literature
overarchingly argues MSSP ACOs increase quality and decrease costs for a particular
managed patient population and the maturation of and participation in the program over
time allows for further successes, but when the relationship of the pertinent variables is
analyzed, there is no statistical significance between Quality Score and Generated Total
Savings/Losses nor Quality Score and Total Assigned Beneficiaries.
Even though the data analysis results showed no statistically significant
relationship between Quality Score and Generated Total Savings/Losses and no
statistically significant relationship between Quality Score and Total Assigned
Beneficiaries for 2018 MSSP ACO provider participants, this study contributed to
positive social change by creating a new vantage point for quantitative review of their
quality, costs and assigned beneficiaries.
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As noted earlier in this study, and still of importance to recall, is the value that
MSSP ACOs bring to the overall U.S. health care system. The literature supports that
MSSP ACOs with elevated quality scores yield higher shared savings.
For future studies, qualitative, I would suggest looking at the same variables in a
different manner or reviewing other/additional variables in the MSSP ACO dataset.
Examples of various ways to look at the data in a quantitative manner include, but are not
limited to, eliminating dollars spent on high-cost services, reviewing certain geographies
and/or capturing only mature ACOs. Additionally, one could include patient satisfaction
survey results, medical home loyalty, in-network service versus out-of-network service
utilization and other factors to review Medicare beneficiary engagement in their overall
health care. Engagement and satisfaction may better represent quality of care analysis in a
qualitative review.
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